+关注
UpUpUpUpUp
暂无个人介绍
IP属地:未知
182
关注
11
粉丝
2
主题
0
勋章
主贴
热门
UpUpUpUpUp
2021-10-20
Like pls!!
Wall Street ends higher as investors bet on positive earnings season
UpUpUpUpUp
2021-10-19
Nice!! Up up!!
Tesla Q3: Blowout Possible Again
UpUpUpUpUp
2021-10-16
Like pls
Wall St ends higher as Goldman rounds out parade of strong bank results
UpUpUpUpUp
2021-10-15
Like pls
Ocugen stock jumped more than 10% in morning trading
UpUpUpUpUp
2021-10-13
Like
Aviation,Cruise Line and bank stocks dipped in morning trading
UpUpUpUpUp
2021-10-11
Like pls!!
Beware Tech Stocks. They Could Be a Trap.
UpUpUpUpUp
2021-10-09
Loke
5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter
UpUpUpUpUp
2021-10-07
Like
Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?
UpUpUpUpUp
2021-10-01
Like pls
Billionaire Bill Ackman is smoking 'mentor' Warren Buffett with these income stocks
UpUpUpUpUp
2021-09-30
Like pls
Eyewear maker Warby Parker spikes 34% on its first day of trading
UpUpUpUpUp
2021-09-29
like pls
Stocks rebound slightly as 10-year yield’s run takes a breather
UpUpUpUpUp
2021-09-28
Why?
抱歉,原内容已删除
UpUpUpUpUp
2021-09-27
Like pls!
Opinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell
UpUpUpUpUp
2021-09-24
Like pls!!
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3575517733011286,"uuid":"3575517733011286","gmtCreate":1612423710283,"gmtModify":1612959119035,"name":"UpUpUpUpUp","pinyin":"upupupupup","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":182,"tweetSize":57,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":859825606,"gmtCreate":1634688403387,"gmtModify":1634688403667,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls!!","listText":"Like pls!!","text":"Like pls!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859825606","repostId":"2176710436","repostType":4,"repost":{"id":"2176710436","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1634683772,"share":"https://www.laohu8.com/m/news/2176710436?lang=&edition=full","pubTime":"2021-10-20 06:49","market":"us","language":"en","title":"Wall Street ends higher as investors bet on positive earnings season","url":"https://stock-news.laohu8.com/highlight/detail?id=2176710436","media":"Reuters","summary":"Oct 19 (Reuters) - U.S. stock indexes closed higher on Tuesday with the biggest boosts from the tech","content":"<p>Oct 19 (Reuters) - U.S. stock indexes closed higher on Tuesday with the biggest boosts from the technology and healthcare sectors as investors appeared to bet on solid quarterly reports even as some worried that it was too early to celebrate.</p>\n<p>In its fifth straight session of gains, the benchmark S&P 500 index finished just 0.4% below its early September record close while the Dow Jones Industrials average ended the day about 0.5% below its record reached in mid-August.</p>\n<p>Johnson & Johnson's shares added 2.3% providing a big boost to the S&P 500 after it raised its 2021 adjusted profit forecast. Insurer Travelers Cos Inc climbed 1.6% after beating its profit estimates.</p>\n<p>High-profile technology and communications companies were also big S&P boosts with Apple Inc, <a href=\"https://laohu8.com/S/FB\">Facebook</a> and Microsoft all rising.</p>\n<p>But in the second week of earnings with a \"very small sample\" of releases, Steve Sosnick, chief strategist at Interactive Brokers, worried about a possible pullback.</p>\n<p>\"We're seeing volatility measures like the VIX flipping from nervous to complacent in a really short period of time,\" said Sosnick. \"We may be a bit ahead of ourselves. The mostly likely scenario is that we make one more run at new S&P highs and then we pull back, subject to earnings.\"</p>\n<p>The CBOE market volatility index fell 0.6 points after earlier hitting 15.57, its lowest level since mid-August.</p>\n<p>Analysts now expect S&P 500 earnings to rise 32.4% from a year earlier, according to Refinitiv data.</p>\n<p>\"The key for the market to going up from here will not be higher multiples, it will have to be higher earnings. That's why it's so important to pay attention to what those profit margins do going forward and what the trajectory of GDP looks like,\" said Eric Marshall, portfolio manager at Hodges Funds.</p>\n<p>\"Investors will be paying very close attention to pricing power, how companies are dealing with labor shortages and inflationary cost pressures within their business.\"</p>\n<p>The Dow Jones Industrial Average rose 198.7 points, or 0.56%, to 35,457.31, the S&P 500 gained 33.17 points, or 0.74%, to 4,519.63 and the Nasdaq Composite added 107.28 points, or 0.71%, to 15,129.09.</p>\n<p>Ten of the eleven major S&P 500 sectors closed higher, with healthcare stocks, up 1.3% after dropping 0.7% in Monday's session. The next biggest gainer was utilities , which rose 1.26% after falling almost 1% Monday.</p>\n<p>Netflix Inc, after closing up 0.2%, declined to gains while the bell when quarterly results showed that global interest in Korean thriller \"Squid Game\" lured more new customers than expected.</p>\n<p>Tesla Inc, which closed down 0.7%, is due to release results on Wednesday, with investors watching for indications of its performance in China.</p>\n<p>Procter & Gamble Co, fell 1% during the session, after it warned that it would have to raise prices of some products to counter higher commodity and freight costs.</p>\n<p>However, Walmart Inc shares added 2% after being added to Goldman Sachs \"Americas Conviction List.\"</p>\n<p>Helping the healthcare sector on Tuesday was drugmaker Merck & Co Inc, which rose 3% while Pfizer Inc climbed 1.9% following the release of a competitor's COVID-19 drug study results.</p>\n<p>Its competitor, Atea Pharmaceuticals Inc, fell 66% after the company's antiviral pill, being developed with Roche , failed to help patients with mild and moderate COVID-19.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.51-to-1 ratio; on Nasdaq, a 1.69-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 44 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 72 new highs and 69 new lows.</p>\n<p>On U.S. exchanges 9.5 billion shares changed hands compared with the 10.29 billion moving average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends higher as investors bet on positive earnings season</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends higher as investors bet on positive earnings season\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-20 06:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oct 19 (Reuters) - U.S. stock indexes closed higher on Tuesday with the biggest boosts from the technology and healthcare sectors as investors appeared to bet on solid quarterly reports even as some worried that it was too early to celebrate.</p>\n<p>In its fifth straight session of gains, the benchmark S&P 500 index finished just 0.4% below its early September record close while the Dow Jones Industrials average ended the day about 0.5% below its record reached in mid-August.</p>\n<p>Johnson & Johnson's shares added 2.3% providing a big boost to the S&P 500 after it raised its 2021 adjusted profit forecast. Insurer Travelers Cos Inc climbed 1.6% after beating its profit estimates.</p>\n<p>High-profile technology and communications companies were also big S&P boosts with Apple Inc, <a href=\"https://laohu8.com/S/FB\">Facebook</a> and Microsoft all rising.</p>\n<p>But in the second week of earnings with a \"very small sample\" of releases, Steve Sosnick, chief strategist at Interactive Brokers, worried about a possible pullback.</p>\n<p>\"We're seeing volatility measures like the VIX flipping from nervous to complacent in a really short period of time,\" said Sosnick. \"We may be a bit ahead of ourselves. The mostly likely scenario is that we make one more run at new S&P highs and then we pull back, subject to earnings.\"</p>\n<p>The CBOE market volatility index fell 0.6 points after earlier hitting 15.57, its lowest level since mid-August.</p>\n<p>Analysts now expect S&P 500 earnings to rise 32.4% from a year earlier, according to Refinitiv data.</p>\n<p>\"The key for the market to going up from here will not be higher multiples, it will have to be higher earnings. That's why it's so important to pay attention to what those profit margins do going forward and what the trajectory of GDP looks like,\" said Eric Marshall, portfolio manager at Hodges Funds.</p>\n<p>\"Investors will be paying very close attention to pricing power, how companies are dealing with labor shortages and inflationary cost pressures within their business.\"</p>\n<p>The Dow Jones Industrial Average rose 198.7 points, or 0.56%, to 35,457.31, the S&P 500 gained 33.17 points, or 0.74%, to 4,519.63 and the Nasdaq Composite added 107.28 points, or 0.71%, to 15,129.09.</p>\n<p>Ten of the eleven major S&P 500 sectors closed higher, with healthcare stocks, up 1.3% after dropping 0.7% in Monday's session. The next biggest gainer was utilities , which rose 1.26% after falling almost 1% Monday.</p>\n<p>Netflix Inc, after closing up 0.2%, declined to gains while the bell when quarterly results showed that global interest in Korean thriller \"Squid Game\" lured more new customers than expected.</p>\n<p>Tesla Inc, which closed down 0.7%, is due to release results on Wednesday, with investors watching for indications of its performance in China.</p>\n<p>Procter & Gamble Co, fell 1% during the session, after it warned that it would have to raise prices of some products to counter higher commodity and freight costs.</p>\n<p>However, Walmart Inc shares added 2% after being added to Goldman Sachs \"Americas Conviction List.\"</p>\n<p>Helping the healthcare sector on Tuesday was drugmaker Merck & Co Inc, which rose 3% while Pfizer Inc climbed 1.9% following the release of a competitor's COVID-19 drug study results.</p>\n<p>Its competitor, Atea Pharmaceuticals Inc, fell 66% after the company's antiviral pill, being developed with Roche , failed to help patients with mild and moderate COVID-19.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.51-to-1 ratio; on Nasdaq, a 1.69-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 44 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 72 new highs and 69 new lows.</p>\n<p>On U.S. exchanges 9.5 billion shares changed hands compared with the 10.29 billion moving average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","WMT":"沃尔玛",".DJI":"道琼斯","PG":"宝洁","MRK":"默沙东",".IXIC":"NASDAQ Composite","TSLA":"特斯拉",".SPX":"S&P 500 Index","NFLX":"奈飞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176710436","content_text":"Oct 19 (Reuters) - U.S. stock indexes closed higher on Tuesday with the biggest boosts from the technology and healthcare sectors as investors appeared to bet on solid quarterly reports even as some worried that it was too early to celebrate.\nIn its fifth straight session of gains, the benchmark S&P 500 index finished just 0.4% below its early September record close while the Dow Jones Industrials average ended the day about 0.5% below its record reached in mid-August.\nJohnson & Johnson's shares added 2.3% providing a big boost to the S&P 500 after it raised its 2021 adjusted profit forecast. Insurer Travelers Cos Inc climbed 1.6% after beating its profit estimates.\nHigh-profile technology and communications companies were also big S&P boosts with Apple Inc, Facebook and Microsoft all rising.\nBut in the second week of earnings with a \"very small sample\" of releases, Steve Sosnick, chief strategist at Interactive Brokers, worried about a possible pullback.\n\"We're seeing volatility measures like the VIX flipping from nervous to complacent in a really short period of time,\" said Sosnick. \"We may be a bit ahead of ourselves. The mostly likely scenario is that we make one more run at new S&P highs and then we pull back, subject to earnings.\"\nThe CBOE market volatility index fell 0.6 points after earlier hitting 15.57, its lowest level since mid-August.\nAnalysts now expect S&P 500 earnings to rise 32.4% from a year earlier, according to Refinitiv data.\n\"The key for the market to going up from here will not be higher multiples, it will have to be higher earnings. That's why it's so important to pay attention to what those profit margins do going forward and what the trajectory of GDP looks like,\" said Eric Marshall, portfolio manager at Hodges Funds.\n\"Investors will be paying very close attention to pricing power, how companies are dealing with labor shortages and inflationary cost pressures within their business.\"\nThe Dow Jones Industrial Average rose 198.7 points, or 0.56%, to 35,457.31, the S&P 500 gained 33.17 points, or 0.74%, to 4,519.63 and the Nasdaq Composite added 107.28 points, or 0.71%, to 15,129.09.\nTen of the eleven major S&P 500 sectors closed higher, with healthcare stocks, up 1.3% after dropping 0.7% in Monday's session. The next biggest gainer was utilities , which rose 1.26% after falling almost 1% Monday.\nNetflix Inc, after closing up 0.2%, declined to gains while the bell when quarterly results showed that global interest in Korean thriller \"Squid Game\" lured more new customers than expected.\nTesla Inc, which closed down 0.7%, is due to release results on Wednesday, with investors watching for indications of its performance in China.\nProcter & Gamble Co, fell 1% during the session, after it warned that it would have to raise prices of some products to counter higher commodity and freight costs.\nHowever, Walmart Inc shares added 2% after being added to Goldman Sachs \"Americas Conviction List.\"\nHelping the healthcare sector on Tuesday was drugmaker Merck & Co Inc, which rose 3% while Pfizer Inc climbed 1.9% following the release of a competitor's COVID-19 drug study results.\nIts competitor, Atea Pharmaceuticals Inc, fell 66% after the company's antiviral pill, being developed with Roche , failed to help patients with mild and moderate COVID-19.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.51-to-1 ratio; on Nasdaq, a 1.69-to-1 ratio favored advancers.\nThe S&P 500 posted 44 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 72 new highs and 69 new lows.\nOn U.S. exchanges 9.5 billion shares changed hands compared with the 10.29 billion moving average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859022245,"gmtCreate":1634642052633,"gmtModify":1634642072315,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!! Up up!!","listText":"Nice!! Up up!!","text":"Nice!! Up up!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859022245","repostId":"1198851965","repostType":4,"repost":{"id":"1198851965","pubTimestamp":1634623112,"share":"https://www.laohu8.com/m/news/1198851965?lang=&edition=full","pubTime":"2021-10-19 13:58","market":"us","language":"en","title":"Tesla Q3: Blowout Possible Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1198851965","media":"Seeking Alpha","summary":"Summary\n\nQ3 street estimates seems rather low.\nMargin strength could lead to large beat.\nInvestors l","content":"<p><b>Summary</b></p>\n<ul>\n <li>Q3 street estimates seems rather low.</li>\n <li>Margin strength could lead to large beat.</li>\n <li>Investors looking for comments on supply chain issues.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5041f66900bbf640321835328ad686ba\" tg-width=\"1536\" tg-height=\"793\" width=\"100%\" height=\"auto\"><span>AdrianHancu/iStock Editorial via Getty Images</span></p>\n<p>All eyes will be on electric vehicle maker Tesla(NASDAQ:TSLA)as the company reports its third quarter results after the bell on Wednesday, October 20th. Recently, the company announced record production and deliveries for the quarter that smashed analyst expectations. However, street estimates for Q3 haven't risen as much as one might expect, which could lead to another blowout earnings report this week.</p>\n<p>For the period, preliminary deliveries of 241,300 beat street estimates by nearly 20,000 units. In Q2 of this year, the average revenue per vehicle delivered (including regulatory credit sales) was just under $50,700. If you basically round off, the math tells you that a beat of that size should equal about an extra billion dollars in revenue. Going into the report, the street was exactly at $13 billion for its Q3 average, but take a look at where we are now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2c6077ce9974face1a7cfbeabe2e93e0\" tg-width=\"640\" tg-height=\"73\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha analyst estimates page</span></p>\n<p>Despite the large deliveries beat, the street average hasn't even risen by $650 million, so the consensus seems to be a bit low right now. Additionally, the \"low\" estimate seems completely off base, as that would represent a decline over Q2's top line figure despite an extra roughly 40,000 deliveries. Don't forget, the sequential jump in Model S cash deliveries was around 6,000 units, which at an average selling price of $100,000 is an additional $600 million in revenue alone. Taking the low estimate out would increase the street average by $100 million. Unless there was some massive discounting going on or some prior period adjustment, any revenue estimates around or below $13 billion just don't seem logical.</p>\n<p>Model Y sales to Europe, more Model S sales (including the expensive Plaid), and a full quarter of price raises in the US should all be tailwinds. The standard range Y in China will provide somewhat of a headwind, along with a slightly stronger dollar in the quarter. However, Tesla may be able to potentially recognize hundreds of millions of dollars in deferred revenue related to its full self-driving feature as that program expanded a bit during the quarter. I also am projecting a $100 million sequential decline in credit sales.</p>\n<p>Perhaps the biggest question in the quarter will be margins. All of those price hikes, the mix of more Model Y and new Model S, and the ramp of production in China should be positives, potentially offsetting some or all supply chain or chip shortage inflation. In my base case, I'm assuming that total automotive gross margins increase by one percentage point, or a little more than half of the 190 basis points they jumped from Q1 to Q2. As I usually do, the table below shows a bear, base, and bull case, with dollar values in millions except per share amounts.</p>\n<p><img src=\"https://static.tigerbbs.com/9f864f8d975853337e47b5f88687b983\" tg-width=\"551\" tg-height=\"595\" width=\"100%\" height=\"auto\">I'm sure there will be critics who think I'm just trying to set a high bar so that Tesla cannot beat my base case. That is not true here, as on the revenue side I'm not even halfway between the street average and the high estimate on the street. On the bottom line, I'm not even calling for Tesla to beat by as much as it did in Q2 (47 cents). Also, using the average jump from Q2 to Q3 non-GAAP earnings per share over the past three years would put us a bit above $2 per share, and I'm still calling for a one handle there. For Tesla to miss estimates on the bottom line, gross margins would have to drop by about a percentage point sequentially. Even then, a little revenue upside or savings on the operating expense lines could still fuel a bottom line beat.</p>\n<p>The other major item investors will be watching for is an update on Tesla's production facilities. It appears that Shanghai 3/Y production is now greater than Fremont's, and the Berlin and Texas factories are still on track to open this year. The company needs these facilities to come online in the next few months if it wants to hit a 50% yearly growth rate for 2022, likely meaning over 1.3 million deliveries. Any Tesla-specific delays that linger meaningfully into the new year may also impact other new products (Semi, Cybertruck, new Roadster) that have already been delayed a bit, as well as allowing the competition to potentially steal some market share. In the past few days, Tesla removed the Cybertruck's specifications and prices from its website. This may have to do with surging commodity costs since that product was unveiled, and it likely means Tesla will raise prices when production finally starts.</p>\n<p>As for Tesla shares, they are currently in a very nice uptrend and have broken solidly above $800 after the Q3 delivery report. As the chart below shows, the 50-day moving average (pink line) has crossed back above its longer term counterpart (200-day in purple). The stock closed Friday less than $60 from its all-time high, so the only concern here might be that the earnings report could be the old \"buy the rumor, sell the news\" type of event.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3d6c847a0a536db8d53da68a6fbbbeac\" tg-width=\"640\" tg-height=\"245\" width=\"100%\" height=\"auto\"><span>Source: Yahoo! Finance</span></p>\n<p>Tesla is set to report Q3 earnings this week, and it would not surprise me if we see the company beat again. Given the sharp sequential rise in deliveries, the street seems a bit low with some of its estimates, and any margin increases would likely mean a significant bottom line beat. Investors will be looking for updates on production capacities, not only to see if Berlin and Texas are close to being ready, but to start thinking about how far over one million deliveries Tesla could get next year. It certainly will be interesting to see the stock's reaction afterwards, as the recent rally may mean investors are pricing in another big beat.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Q3: Blowout Possible Again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Q3: Blowout Possible Again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-19 13:58 GMT+8 <a href=https://seekingalpha.com/article/4460443-tesla-stock-blowout-q3-possible-again><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nQ3 street estimates seems rather low.\nMargin strength could lead to large beat.\nInvestors looking for comments on supply chain issues.\n\nAdrianHancu/iStock Editorial via Getty Images\nAll eyes ...</p>\n\n<a href=\"https://seekingalpha.com/article/4460443-tesla-stock-blowout-q3-possible-again\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4460443-tesla-stock-blowout-q3-possible-again","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198851965","content_text":"Summary\n\nQ3 street estimates seems rather low.\nMargin strength could lead to large beat.\nInvestors looking for comments on supply chain issues.\n\nAdrianHancu/iStock Editorial via Getty Images\nAll eyes will be on electric vehicle maker Tesla(NASDAQ:TSLA)as the company reports its third quarter results after the bell on Wednesday, October 20th. Recently, the company announced record production and deliveries for the quarter that smashed analyst expectations. However, street estimates for Q3 haven't risen as much as one might expect, which could lead to another blowout earnings report this week.\nFor the period, preliminary deliveries of 241,300 beat street estimates by nearly 20,000 units. In Q2 of this year, the average revenue per vehicle delivered (including regulatory credit sales) was just under $50,700. If you basically round off, the math tells you that a beat of that size should equal about an extra billion dollars in revenue. Going into the report, the street was exactly at $13 billion for its Q3 average, but take a look at where we are now.\nSource: Seeking Alpha analyst estimates page\nDespite the large deliveries beat, the street average hasn't even risen by $650 million, so the consensus seems to be a bit low right now. Additionally, the \"low\" estimate seems completely off base, as that would represent a decline over Q2's top line figure despite an extra roughly 40,000 deliveries. Don't forget, the sequential jump in Model S cash deliveries was around 6,000 units, which at an average selling price of $100,000 is an additional $600 million in revenue alone. Taking the low estimate out would increase the street average by $100 million. Unless there was some massive discounting going on or some prior period adjustment, any revenue estimates around or below $13 billion just don't seem logical.\nModel Y sales to Europe, more Model S sales (including the expensive Plaid), and a full quarter of price raises in the US should all be tailwinds. The standard range Y in China will provide somewhat of a headwind, along with a slightly stronger dollar in the quarter. However, Tesla may be able to potentially recognize hundreds of millions of dollars in deferred revenue related to its full self-driving feature as that program expanded a bit during the quarter. I also am projecting a $100 million sequential decline in credit sales.\nPerhaps the biggest question in the quarter will be margins. All of those price hikes, the mix of more Model Y and new Model S, and the ramp of production in China should be positives, potentially offsetting some or all supply chain or chip shortage inflation. In my base case, I'm assuming that total automotive gross margins increase by one percentage point, or a little more than half of the 190 basis points they jumped from Q1 to Q2. As I usually do, the table below shows a bear, base, and bull case, with dollar values in millions except per share amounts.\nI'm sure there will be critics who think I'm just trying to set a high bar so that Tesla cannot beat my base case. That is not true here, as on the revenue side I'm not even halfway between the street average and the high estimate on the street. On the bottom line, I'm not even calling for Tesla to beat by as much as it did in Q2 (47 cents). Also, using the average jump from Q2 to Q3 non-GAAP earnings per share over the past three years would put us a bit above $2 per share, and I'm still calling for a one handle there. For Tesla to miss estimates on the bottom line, gross margins would have to drop by about a percentage point sequentially. Even then, a little revenue upside or savings on the operating expense lines could still fuel a bottom line beat.\nThe other major item investors will be watching for is an update on Tesla's production facilities. It appears that Shanghai 3/Y production is now greater than Fremont's, and the Berlin and Texas factories are still on track to open this year. The company needs these facilities to come online in the next few months if it wants to hit a 50% yearly growth rate for 2022, likely meaning over 1.3 million deliveries. Any Tesla-specific delays that linger meaningfully into the new year may also impact other new products (Semi, Cybertruck, new Roadster) that have already been delayed a bit, as well as allowing the competition to potentially steal some market share. In the past few days, Tesla removed the Cybertruck's specifications and prices from its website. This may have to do with surging commodity costs since that product was unveiled, and it likely means Tesla will raise prices when production finally starts.\nAs for Tesla shares, they are currently in a very nice uptrend and have broken solidly above $800 after the Q3 delivery report. As the chart below shows, the 50-day moving average (pink line) has crossed back above its longer term counterpart (200-day in purple). The stock closed Friday less than $60 from its all-time high, so the only concern here might be that the earnings report could be the old \"buy the rumor, sell the news\" type of event.\nSource: Yahoo! Finance\nTesla is set to report Q3 earnings this week, and it would not surprise me if we see the company beat again. Given the sharp sequential rise in deliveries, the street seems a bit low with some of its estimates, and any margin increases would likely mean a significant bottom line beat. Investors will be looking for updates on production capacities, not only to see if Berlin and Texas are close to being ready, but to start thinking about how far over one million deliveries Tesla could get next year. It certainly will be interesting to see the stock's reaction afterwards, as the recent rally may mean investors are pricing in another big beat.","news_type":1},"isVote":1,"tweetType":1,"viewCount":491,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":827030112,"gmtCreate":1634364716783,"gmtModify":1634364717065,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/827030112","repostId":"2175146556","repostType":4,"repost":{"id":"2175146556","pubTimestamp":1634328035,"share":"https://www.laohu8.com/m/news/2175146556?lang=&edition=full","pubTime":"2021-10-16 04:00","market":"us","language":"en","title":"Wall St ends higher as Goldman rounds out parade of strong bank results","url":"https://stock-news.laohu8.com/highlight/detail?id=2175146556","media":"Reuters","summary":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news","content":"<p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)</p>\n<ul>\n <li>Retail sales up 0.7% in September despite shortages</li>\n <li>Goldman Sachs rises on strong third-quarter earnings (New throughout, updates prices, market activity and comments to close)</li>\n</ul>\n<p>NEW YORK, Oct 15 (Reuters) - U.S. stocks ended higher on Friday after Goldman Sachs became the latest big bank to report strong quarterly earnings, and Wall Street's three major indexes posted gains for the week.</p>\n<p>Goldman Sachs Group shares jumped, giving the Dow its biggest boost, as a record wave of dealmaking activity drove a surge in the bank's quarterly profit.</p>\n<p>Other big lenders also rose and were among the biggest positive for the S&P 500. The index's bank index ended sharply higher.</p>\n<p>Results from the big financial institutions this week have provided a strong start to third-quarter U.S. earnings, though investors will still watch in coming weeks for signs of impacts from supply chain disruptions and higher costs, especially for energy.</p>\n<p>Forecasts now call for S&P 500 earnings to show a 32% rise in the third quarter from a year ago. The latest forecast, based on results from 41 of the S&P 500 companies and estimates for the rest, is up from 29.4% at the start of October, according to IBES data from Refinitiv.</p>\n<p>\"We're starting to get into an earnings-driven rally here that I hope lasts. We'll really see the results in the next couple of weeks as a great bulk of companies in all sectors report,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Alcoa Corp shares surged after the aluminum producer reported stronger-than-expected results, announced a $500 million buyback program and initiated a quarterly cash dividend.</p>\n<p>According to preliminary data, the S&P 500 gained 33.35 points, or 0.75%, to end at 4,471.61 points, while the Nasdaq Composite gained 73.55 points, or 0.50%, to 14,896.98. The Dow Jones Industrial Average rose 384.83 points, or 1.10%, to 35,297.39.</p>\n<p>The U.S. Commerce Department reported a surprise rise in retail sales in September, although investors still worried that supply constraints could disrupt the holiday shopping season. A preliminary reading for consumer sentiment in October came in slightly below expectations.</p>\n<p>Some airline and other travel-related company shares edged higher, with the White House announcing it will lift travel restrictions for fully-vaccinated foreign nationals effective Nov. 8.</p>\n<p>Moderna Inc shares were lower. A Wall Street Journal report, citing people familiar with the matter, said the U.S. Food and Drug Administration is delaying its decision on authorizing Moderna's COVID-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation.</p>\n<p>On Thursday, an FDA panel voted to recommend booster shots of its COVID-19 vaccine for Americans aged 65 and older and high-risk people.</p>\n<p>Shares of cryptocurrency and blockchain-related firms including Riot Blockchain gained as bitcoin hit $60,000 for the first time since April. (Additional reporting by Devik Jain in Bengaluru and Federica Urso in Gdansk; Editing by Anil D'Silva, Arun Koyyur and Nick Zieminski)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends higher as Goldman rounds out parade of strong bank results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends higher as Goldman rounds out parade of strong bank results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-16 04:00 GMT+8 <a href=https://finance.yahoo.com/news/us-stocks-wall-st-ends-200035041.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)\n\nRetail sales up 0.7% in September despite shortages\nGoldman Sachs rises on strong third-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-ends-200035041.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COMP":"Compass, Inc.","GS":"高盛","GSBD":"高盛BDC基金"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-ends-200035041.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2175146556","content_text":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)\n\nRetail sales up 0.7% in September despite shortages\nGoldman Sachs rises on strong third-quarter earnings (New throughout, updates prices, market activity and comments to close)\n\nNEW YORK, Oct 15 (Reuters) - U.S. stocks ended higher on Friday after Goldman Sachs became the latest big bank to report strong quarterly earnings, and Wall Street's three major indexes posted gains for the week.\nGoldman Sachs Group shares jumped, giving the Dow its biggest boost, as a record wave of dealmaking activity drove a surge in the bank's quarterly profit.\nOther big lenders also rose and were among the biggest positive for the S&P 500. The index's bank index ended sharply higher.\nResults from the big financial institutions this week have provided a strong start to third-quarter U.S. earnings, though investors will still watch in coming weeks for signs of impacts from supply chain disruptions and higher costs, especially for energy.\nForecasts now call for S&P 500 earnings to show a 32% rise in the third quarter from a year ago. The latest forecast, based on results from 41 of the S&P 500 companies and estimates for the rest, is up from 29.4% at the start of October, according to IBES data from Refinitiv.\n\"We're starting to get into an earnings-driven rally here that I hope lasts. We'll really see the results in the next couple of weeks as a great bulk of companies in all sectors report,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.\nAlcoa Corp shares surged after the aluminum producer reported stronger-than-expected results, announced a $500 million buyback program and initiated a quarterly cash dividend.\nAccording to preliminary data, the S&P 500 gained 33.35 points, or 0.75%, to end at 4,471.61 points, while the Nasdaq Composite gained 73.55 points, or 0.50%, to 14,896.98. The Dow Jones Industrial Average rose 384.83 points, or 1.10%, to 35,297.39.\nThe U.S. Commerce Department reported a surprise rise in retail sales in September, although investors still worried that supply constraints could disrupt the holiday shopping season. A preliminary reading for consumer sentiment in October came in slightly below expectations.\nSome airline and other travel-related company shares edged higher, with the White House announcing it will lift travel restrictions for fully-vaccinated foreign nationals effective Nov. 8.\nModerna Inc shares were lower. A Wall Street Journal report, citing people familiar with the matter, said the U.S. Food and Drug Administration is delaying its decision on authorizing Moderna's COVID-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation.\nOn Thursday, an FDA panel voted to recommend booster shots of its COVID-19 vaccine for Americans aged 65 and older and high-risk people.\nShares of cryptocurrency and blockchain-related firms including Riot Blockchain gained as bitcoin hit $60,000 for the first time since April. (Additional reporting by Devik Jain in Bengaluru and Federica Urso in Gdansk; Editing by Anil D'Silva, Arun Koyyur and Nick Zieminski)","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":825212577,"gmtCreate":1634227219177,"gmtModify":1634227219177,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/825212577","repostId":"1108820000","repostType":4,"repost":{"id":"1108820000","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634225594,"share":"https://www.laohu8.com/m/news/1108820000?lang=&edition=full","pubTime":"2021-10-14 23:33","market":"us","language":"en","title":"Ocugen stock jumped more than 10% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1108820000","media":"Tiger Newspress","summary":"Ocugen stock jumped more than 10% in morning trading.The share rose more than 40% this week.\n\nThe bi","content":"<p>Ocugen stock jumped more than 10% in morning trading.The share rose more than 40% this week.</p>\n<p><img src=\"https://static.tigerbbs.com/4d6529ae3a1b252bbc25776ab15e3e3c\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>The biotech's stock is moving northward this morning on the news that the COVID-19 vaccine, Covaxin, was granted emergency use approval for children ages 2 to 18 by India's Subject Expert Committee. This vaccine is among the first to receive such a broad emergency use authorization label in the entire world.</p>\n<p>Ocugen is partnered with India's Bharat Biotech to commercialize Covaxin in Canada and the United States. The pair are now waiting on word from the World Health Organization on the vaccine's emergency use application. This critical regulatory decision is expected any day now.</p>\n<p>Ocugen's goal is to become an important second- to third-tier COVID-19 vaccine player in key developed markets like Canada and the United States. The problem with this strategy is that there are already a surfeit of novel coronavirus vaccines in these high-value territories, with more on the way.<b>Novavax</b>'s highly anticipated COVID-19 vaccine known as NVX-CoV2373, for example, should be available in the U.S. early in 2022. As a result, it's not entirely clear how much of a commercial opportunity will be left for late-comers like Ocugen.</p>\n<p>Is Ocugen's stock a buy on this news? This is an extremely positive regulatory development, to be sure. But it is unlikely to have any bearing on the vaccine's regulatory fate in either Canada or the United States.</p>\n<p>That said, the biotech's shares should still perform well over the long term. If the vaccine can carve out a profitable niche in these increasingly crowded markets where the company owns a commercial license, Ocugen could end up with a healthy and perhaps fairly long-lived revenue stream.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen stock jumped more than 10% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen stock jumped more than 10% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-14 23:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen stock jumped more than 10% in morning trading.The share rose more than 40% this week.</p>\n<p><img src=\"https://static.tigerbbs.com/4d6529ae3a1b252bbc25776ab15e3e3c\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>The biotech's stock is moving northward this morning on the news that the COVID-19 vaccine, Covaxin, was granted emergency use approval for children ages 2 to 18 by India's Subject Expert Committee. This vaccine is among the first to receive such a broad emergency use authorization label in the entire world.</p>\n<p>Ocugen is partnered with India's Bharat Biotech to commercialize Covaxin in Canada and the United States. The pair are now waiting on word from the World Health Organization on the vaccine's emergency use application. This critical regulatory decision is expected any day now.</p>\n<p>Ocugen's goal is to become an important second- to third-tier COVID-19 vaccine player in key developed markets like Canada and the United States. The problem with this strategy is that there are already a surfeit of novel coronavirus vaccines in these high-value territories, with more on the way.<b>Novavax</b>'s highly anticipated COVID-19 vaccine known as NVX-CoV2373, for example, should be available in the U.S. early in 2022. As a result, it's not entirely clear how much of a commercial opportunity will be left for late-comers like Ocugen.</p>\n<p>Is Ocugen's stock a buy on this news? This is an extremely positive regulatory development, to be sure. But it is unlikely to have any bearing on the vaccine's regulatory fate in either Canada or the United States.</p>\n<p>That said, the biotech's shares should still perform well over the long term. If the vaccine can carve out a profitable niche in these increasingly crowded markets where the company owns a commercial license, Ocugen could end up with a healthy and perhaps fairly long-lived revenue stream.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108820000","content_text":"Ocugen stock jumped more than 10% in morning trading.The share rose more than 40% this week.\n\nThe biotech's stock is moving northward this morning on the news that the COVID-19 vaccine, Covaxin, was granted emergency use approval for children ages 2 to 18 by India's Subject Expert Committee. This vaccine is among the first to receive such a broad emergency use authorization label in the entire world.\nOcugen is partnered with India's Bharat Biotech to commercialize Covaxin in Canada and the United States. The pair are now waiting on word from the World Health Organization on the vaccine's emergency use application. This critical regulatory decision is expected any day now.\nOcugen's goal is to become an important second- to third-tier COVID-19 vaccine player in key developed markets like Canada and the United States. The problem with this strategy is that there are already a surfeit of novel coronavirus vaccines in these high-value territories, with more on the way.Novavax's highly anticipated COVID-19 vaccine known as NVX-CoV2373, for example, should be available in the U.S. early in 2022. As a result, it's not entirely clear how much of a commercial opportunity will be left for late-comers like Ocugen.\nIs Ocugen's stock a buy on this news? This is an extremely positive regulatory development, to be sure. But it is unlikely to have any bearing on the vaccine's regulatory fate in either Canada or the United States.\nThat said, the biotech's shares should still perform well over the long term. If the vaccine can carve out a profitable niche in these increasingly crowded markets where the company owns a commercial license, Ocugen could end up with a healthy and perhaps fairly long-lived revenue stream.","news_type":1},"isVote":1,"tweetType":1,"viewCount":249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":822215628,"gmtCreate":1634134333390,"gmtModify":1634134333485,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/822215628","repostId":"1155202922","repostType":4,"repost":{"id":"1155202922","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634133901,"share":"https://www.laohu8.com/m/news/1155202922?lang=&edition=full","pubTime":"2021-10-13 22:05","market":"us","language":"en","title":"Aviation,Cruise Line and bank stocks dipped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1155202922","media":"Tiger Newspress","summary":"Aviation,Cruise Line and bank stocks dipped in morning trading.","content":"<p>Aviation,Cruise Line and bank stocks dipped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/170a848bdb8d9df6aac064350be93df9\" tg-width=\"411\" tg-height=\"484\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/edda66dde88fc8119015bf68cd100f80\" tg-width=\"402\" tg-height=\"185\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/51775b4b2efca14f1f5078de1ae25948\" tg-width=\"416\" tg-height=\"661\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aviation,Cruise Line and bank stocks dipped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAviation,Cruise Line and bank stocks dipped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-13 22:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aviation,Cruise Line and bank stocks dipped in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/170a848bdb8d9df6aac064350be93df9\" tg-width=\"411\" tg-height=\"484\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/edda66dde88fc8119015bf68cd100f80\" tg-width=\"402\" tg-height=\"185\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/51775b4b2efca14f1f5078de1ae25948\" tg-width=\"416\" tg-height=\"661\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JPM":"摩根大通","WFC":"富国银行","SAVE":"Spirit Airlines","AAL":"美国航空","CCL":"嘉年华邮轮","JBLU":"捷蓝航空","BA":"波音","UAL":"联合大陆航空","TD":"道明银行","ALK":"阿拉斯加航空集团有限公司","LUV":"西南航空","BAC":"美国银行","GS":"高盛","RCL":"皇家加勒比邮轮","NCLH":"挪威邮轮","DAL":"达美航空","MS":"摩根士丹利","C":"花旗"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155202922","content_text":"Aviation,Cruise Line and bank stocks dipped in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":610,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826044916,"gmtCreate":1633961213185,"gmtModify":1633961213298,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls!!","listText":"Like pls!!","text":"Like pls!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/826044916","repostId":"1180287437","repostType":4,"repost":{"id":"1180287437","pubTimestamp":1633937367,"share":"https://www.laohu8.com/m/news/1180287437?lang=&edition=full","pubTime":"2021-10-11 15:29","market":"us","language":"en","title":"Beware Tech Stocks. They Could Be a Trap.","url":"https://stock-news.laohu8.com/highlight/detail?id=1180287437","media":"Barrons","summary":"Bond yields are rising—and that could be bad news for Apple and the rest of Big Tech.\nThere’s no que","content":"<p>Bond yields are rising—and that could be bad news for Apple and the rest of Big Tech.</p>\n<p>There’s no question the Nasdaq 100,an index comprised of large-cap tech companies, has suffered a lot of pain recently. It dropped 7.7% from its Sept. 7 all-time high through Oct. 4, as the 10-year Treasury yield surged to 1.61% from a September low of 1.29%. The yield’s spike began when the Federal Reserve confirmed it is likely to soon begin reducing its monthly bond purchases—something the disappointing September jobs report is unlikely to change. Rising yields are generally bad news for fast-growing tech stocks with nosebleed valuations—and others expected to have large profits many years in the future—by making those profits less valuable.</p>\n<p>The selloff has dissipated in the past few days, with the Nasdaq 100 up 2.5% from the Oct. 4 low as bond yields momentarily stopped rising, perhaps making it look like the worst was over for tech investors. That’s far from a sure bet.</p>\n<p>Bond yields appear to be rising again, which means tech stocks may not be out of the woods yet. Indeed, bond yields look low. Analysts have recently noted that the 10-year yield could easily head up to above 1.7% soon. Not only is Fed policy a factor, but the yield already looks low compared with inflation: The 10-year’s real yield—its yield minus long-term inflation expectations—is still below 0%, meaning that investors are losing value when factoring in inflation.</p>\n<p>The yield’s 2021 peak was 1.75%, and once it moves meaningfully higher than 1.6%, it can revisit that high fairly quickly, says John Kolovos, chief technical strategist at Macro Risk Advisors. The 10-year closed at 1.6% on Friday.</p>\n<p>That could mean big problems for the Nasdaq 100. When the yield was a touch above 1.75% at the end of 2019, the average forward one-year earnings multiple on the index was 23.7 times, according to FactSet. Today, that multiple stands at 27.6 times. “There’s this area within the chart between 1.6% and 1.7% that could pose a problem for tech,” Kolovos says, adding that the index could drop another 5% from here.</p>\n<p>Others see even more downside ahead. Frank Cappelleri, chief market technician at Instinet, notes that the Nasdaq 100 has usually held support around 14,800, but couldn’t do it this time. That indicates the index could soon fall another 6% from here.</p>\n<p>It isn’t all bad news for tech investors, though. DataTrek founder Nicholas Colas notes that analysts have slashed their forecasts for Alphabet (ticker: GOOGL) and Amazon.com (AMZN), while keeping their forecasts for Apple (AAPL),Microsoft (MSFT), and Facebook (FB) unchanged. That gives tech stocks a low bar to jump over when it becomes time to report earnings in a couple of weeks. “The funny thing about all these estimates is that in every single case, they are lower than what these companies reported” in the second quarter, Colas explains. “That’s likely too pessimistic.”</p>\n<p>When tech stocks do find a bottom, the more profitable, scaled, and dominant companies should be reliable picks. Those are often seen as shoo-ins for several years of fast earnings growth, which can bring their stocks higher—so long as their earnings multiples are reasonable.</p>\n<p>“It’s fairly inevitable those businesses will continue to grow,” says David Miller, chief investment officer of Catalyst Capital Advisors. “Some of these growth companies are just so dominant, even with rates going up, they’re still probably worth it.”</p>\n<p>Just wait for yields to stop rising before diving in.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beware Tech Stocks. They Could Be a Trap.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeware Tech Stocks. They Could Be a Trap.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-11 15:29 GMT+8 <a href=https://www.barrons.com/articles/tech-stocks-51633741306?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bond yields are rising—and that could be bad news for Apple and the rest of Big Tech.\nThere’s no question the Nasdaq 100,an index comprised of large-cap tech companies, has suffered a lot of pain ...</p>\n\n<a href=\"https://www.barrons.com/articles/tech-stocks-51633741306?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","AAPL":"苹果","QQQ":"纳指100ETF","NFLX":"奈飞","NDX":"纳斯达克100指数","AMZN":"亚马逊","MSFT":"微软","GOOG":"谷歌","GOOGL":"谷歌A"},"source_url":"https://www.barrons.com/articles/tech-stocks-51633741306?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180287437","content_text":"Bond yields are rising—and that could be bad news for Apple and the rest of Big Tech.\nThere’s no question the Nasdaq 100,an index comprised of large-cap tech companies, has suffered a lot of pain recently. It dropped 7.7% from its Sept. 7 all-time high through Oct. 4, as the 10-year Treasury yield surged to 1.61% from a September low of 1.29%. The yield’s spike began when the Federal Reserve confirmed it is likely to soon begin reducing its monthly bond purchases—something the disappointing September jobs report is unlikely to change. Rising yields are generally bad news for fast-growing tech stocks with nosebleed valuations—and others expected to have large profits many years in the future—by making those profits less valuable.\nThe selloff has dissipated in the past few days, with the Nasdaq 100 up 2.5% from the Oct. 4 low as bond yields momentarily stopped rising, perhaps making it look like the worst was over for tech investors. That’s far from a sure bet.\nBond yields appear to be rising again, which means tech stocks may not be out of the woods yet. Indeed, bond yields look low. Analysts have recently noted that the 10-year yield could easily head up to above 1.7% soon. Not only is Fed policy a factor, but the yield already looks low compared with inflation: The 10-year’s real yield—its yield minus long-term inflation expectations—is still below 0%, meaning that investors are losing value when factoring in inflation.\nThe yield’s 2021 peak was 1.75%, and once it moves meaningfully higher than 1.6%, it can revisit that high fairly quickly, says John Kolovos, chief technical strategist at Macro Risk Advisors. The 10-year closed at 1.6% on Friday.\nThat could mean big problems for the Nasdaq 100. When the yield was a touch above 1.75% at the end of 2019, the average forward one-year earnings multiple on the index was 23.7 times, according to FactSet. Today, that multiple stands at 27.6 times. “There’s this area within the chart between 1.6% and 1.7% that could pose a problem for tech,” Kolovos says, adding that the index could drop another 5% from here.\nOthers see even more downside ahead. Frank Cappelleri, chief market technician at Instinet, notes that the Nasdaq 100 has usually held support around 14,800, but couldn’t do it this time. That indicates the index could soon fall another 6% from here.\nIt isn’t all bad news for tech investors, though. DataTrek founder Nicholas Colas notes that analysts have slashed their forecasts for Alphabet (ticker: GOOGL) and Amazon.com (AMZN), while keeping their forecasts for Apple (AAPL),Microsoft (MSFT), and Facebook (FB) unchanged. That gives tech stocks a low bar to jump over when it becomes time to report earnings in a couple of weeks. “The funny thing about all these estimates is that in every single case, they are lower than what these companies reported” in the second quarter, Colas explains. “That’s likely too pessimistic.”\nWhen tech stocks do find a bottom, the more profitable, scaled, and dominant companies should be reliable picks. Those are often seen as shoo-ins for several years of fast earnings growth, which can bring their stocks higher—so long as their earnings multiples are reasonable.\n“It’s fairly inevitable those businesses will continue to grow,” says David Miller, chief investment officer of Catalyst Capital Advisors. “Some of these growth companies are just so dominant, even with rates going up, they’re still probably worth it.”\nJust wait for yields to stop rising before diving in.","news_type":1},"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821147450,"gmtCreate":1633710001100,"gmtModify":1633710157295,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Loke","listText":"Loke","text":"Loke","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821147450","repostId":"2173925535","repostType":4,"repost":{"id":"2173925535","pubTimestamp":1633701180,"share":"https://www.laohu8.com/m/news/2173925535?lang=&edition=full","pubTime":"2021-10-08 21:53","market":"us","language":"en","title":"5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2173925535","media":"Motley Fool","summary":"Riding the Oracle of Omaha's coattails has long been a moneymaking strategy.","content":"<blockquote>\n <b>Riding the <a href=\"https://laohu8.com/S/ORCL\">Oracle</a> of Omaha's coattails has long been a moneymaking strategy.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>Buffett has delivered an average annual return of 20% for his company's shareholders, dating back to 1965.</li>\n <li><a href=\"https://laohu8.com/S/BRK.A\">Berkshire Hathaway</a>'s investment portfolio is packed with growth and value stocks that are ripe for the picking.</li>\n</ul>\n<p>If you've ever wondered why Wall Street and retail investors pay such close attention to billionaire Warren Buffett, it's because he has an impeccable moneymaking track record.</p>\n<p>Since taking over as CEO of <b><a href=\"https://laohu8.com/S/BRK.B\">Berkshire Hathaway</a></b> (NYSE:BRK.A)(NYSE:BRK.B) in 1965, the Oracle of Omaha has overseen the creation of nearly $600 billion in market value for shareholders, and delivered an average annual return of 20% for the company's Class A shares. Including year-to-date gains, we're talking about an increase of approximately 3,300,000%! Riding Buffett's coattails has long been a profitable venture.</p>\n<p>As we push into the fourth quarter, five Warren Buffett stocks look particularly attractive and can confidently be bought hand over fist by investors.</p>\n<p><img src=\"https://static.tigerbbs.com/1077c8372814d2b8150e933b4c608005\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.</p>\n<h3><a href=\"https://laohu8.com/S/GM\">General Motors</a></h3>\n<p>One of the best deals long-term investors are going to find in Berkshire Hathaway's portfolio at the moment is auto stock <b><a href=\"https://laohu8.com/S/BGC\">General</a> Motors</b> (NYSE:GM).</p>\n<p>Like most automakers, GM has had to contend with two big hurdles over the past 18 months. <a href=\"https://laohu8.com/S/FBNC\">First</a>, the pandemic caused consumers to scale back on major purchases, which reduced short-term auto sales at the dealership level. And second, supply chain issues in the wake of the pandemic have caused GM and other automakers to lower or halt production on certain models. While these concerns are tangible, they're not a long-term worry. This means whatever short-term pain General Motors is experiencing is an opportunity for patient investors to pounce.</p>\n<p>The real excitement for GM has to do with the electrification of consumer and enterprise auto fleets. In an effort to combat climate change, we're liable to see a multi-decade vehicle replacement cycle that almost exclusively emphasizes electric-powered vehicles. For its part, General Motors is investing $35 billion in electric vehicle (EVs), autonomous vehicle, and battery research through 2025. By mid-decade, the company expects to have launched 30 new EVs globally.</p>\n<p>While General Motors has long been a key player in its home market, the U.S., it's no slouch in the world's biggest auto market, either. GM is on pace to sell about 3 million vehicles in <a href=\"https://laohu8.com/S/CAAS\">China</a> this year (based on sales through the first six months), and has the deep pockets and infrastructure capable of gobbling up EV market share in the world's second-largest economy by gross domestic product.</p>\n<p>Long story short, a forward price-to-earnings (P/E) ratio of 8 no longer makes sense for a company whose growth rate could sustainably pick up for decades.</p>\n<p><img src=\"https://static.tigerbbs.com/cf0f5b723e57653031556b63cd5a86db\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>Bristol <a href=\"https://laohu8.com/S/MYE\">Myers</a> Squibb</h3>\n<p>Value stocks have always been a big theme for Warren Buffett, and that's exactly what investors are going to get with pharmaceutical stock <b>Bristol Myers Squibb</b> (NYSE:BMY).</p>\n<p>Like most healthcare stocks, Bristol Myers' products are highly defensive. This is to say that a stock market decline or even an economic contraction won't adversely affect demand for its pharmaceuticals. Since we don't get to choose when we get sick or what ailment(s) we develop, drugmakers like Bristol Myers usually offer highly predictable cash flow.</p>\n<p>One company-specific reason investors can buy this Warren Buffett stock hand over fist for the fourth quarter is its organic growth opportunity. Eliquis, which was developed with <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>, has become the most-popular oral anticoagulant in the world and should bring in more than $10 billion in sales for Bristol Myers Squibb this year. There's also cancer immunotherapy Opdivo, which I believe offers even more long-term opportunity. Although Opdivo flamed out in advanced lung cancer trials a few years back, it's being examined in dozens of clinical trials and has a very good chance to generate billions in added annual revenue via label expansion opportunities.</p>\n<p>Bristol Myers' acquisition of cancer and immunology drugmaker <a href=\"https://laohu8.com/S/CELG\">Celgene</a> in late 2019 gets high marks, too. Buying Celgene brought multiple myeloma drug Revlimid into Bristol's portfolio. Revlimid brought in over $12 billion in sales last year, and has a track record of maintaining double-digit annual sales growth. This key therapy is protected from an onslaught of generic competition until the end of January 2026.</p>\n<p>There aren't many better values right now than Bristol Myers Squibb at less than 8 times Wall Street's forward-year earnings forecast.</p>\n<p><img src=\"https://static.tigerbbs.com/d80a8204e79140f358607acd8fb20af9\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3><a href=\"https://laohu8.com/S/TEVA\">Teva Pharmaceutical</a> Industries</h3>\n<p>In terms of valuation, no Warren Buffett stock is cheaper than brand-name and generic-drug company <b>Teva Pharmaceutical Industries</b> (NYSE:TEVA). Shares of the company can be scooped up by investors right now for under 4 times forecasted earnings per share in 2021.</p>\n<p>How does a profitable company in a defensive sector get pushed to such a low multiple? The truth is Teva has had a lot of things go wrong over the past five years. It overpaid for generic-drug company Actavis, which ballooned its debt, and it's found itself in the crosshairs of litigation on more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> occasion. In fact, most U.S. states are litigating against Teva regarding its role in opioid crisis. The uncertainty surrounding these cases is primarily responsible for keeping Teva's valuation in check.</p>\n<p>Thankfully, Teva has a secret weapon: CEO Kare Schultz. Schultz was hired in late 2017 as a turnaround specialist, and through nearly four years with the company he's worked wonders. Billions in annual operating expenses have been shed, and the company's net debt has shrunk from more than $34 billion when he took over to less than $24 billion. At the current trajectory, Teva could have around $15 billion in net debt by the end of 2023.</p>\n<p>What's more, Schultz has the acumen to work out settlements for Teva's remaining legal issues. Considering Teva's debt position, Schultz is angling to offer free or discounted products, rather than pay cash. With most other drugmakers settling their opioid lawsuits, it seems to be just a matter of time before this gray cloud clears up and Teva returns to a fair valuation multiple.</p>\n<p><img src=\"https://static.tigerbbs.com/fc80e4dea1a6f3868ca4f03e6ea300ae\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3><a href=\"https://laohu8.com/S/V\">Visa</a> and Mastercard</h3>\n<p>The final two Warren Buffett stocks to buy hand over fist for the fourth quarter are being lumped together for good reason: They're chief competitors and two of the most dominant companies in the payment-processing landscape, <b><a href=\"https://laohu8.com/S/V\">Visa</a></b> (NYSE:V) and <b>Mastercard</b> (NYSE:MA).</p>\n<p>The reason Visa and Mastercard have performed so well for so long is because they're cyclically tied companies. Although economic contractions and recessions are inevitable, they usually only last for a few months to a couple of quarters. Comparatively, periods of economic expansion last years. Payment processors Visa and Mastercard are simply benefiting from these disproportionately longer periods of expansion.</p>\n<p>This dynamic duo also outperforms because they strictly stick to payment processing and aren't direct lenders. While it could be argued that they're giving up the opportunity to generate interest income and fees during these long-winded expansions, they're also shielded from a rise in credit delinquencies during economic contractions and recessions. Not having to set aside capital to cover credit delinquencies is a big reason why their profit margins remain so consistently high.</p>\n<p>There's also a long runway for organic expansion with both companies. Most global transactions are still be conducted in cash, and a number of regions are remain underbanked (e.g., Southeastern Asia, the Middle East, and Africa). Pushing their payment infrastructure into these regions should allow Visa and Mastercard to sustain high single-digit sales growth for a long time to come.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-08 21:53 GMT+8 <a href=https://www.fool.com/investing/2021/10/08/5-warren-buffett-stocks-to-buy-for-fourth-quarter/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Riding the Oracle of Omaha's coattails has long been a moneymaking strategy.\n\nKey Points\n\nBuffett has delivered an average annual return of 20% for his company's shareholders, dating back to 1965.\n...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/08/5-warren-buffett-stocks-to-buy-for-fourth-quarter/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","BRK.A":"伯克希尔","BMY":"施贵宝","BRK.B":"伯克希尔B","TEVA":"梯瓦制药","V":"Visa","MA":"万事达"},"source_url":"https://www.fool.com/investing/2021/10/08/5-warren-buffett-stocks-to-buy-for-fourth-quarter/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173925535","content_text":"Riding the Oracle of Omaha's coattails has long been a moneymaking strategy.\n\nKey Points\n\nBuffett has delivered an average annual return of 20% for his company's shareholders, dating back to 1965.\nBerkshire Hathaway's investment portfolio is packed with growth and value stocks that are ripe for the picking.\n\nIf you've ever wondered why Wall Street and retail investors pay such close attention to billionaire Warren Buffett, it's because he has an impeccable moneymaking track record.\nSince taking over as CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) in 1965, the Oracle of Omaha has overseen the creation of nearly $600 billion in market value for shareholders, and delivered an average annual return of 20% for the company's Class A shares. Including year-to-date gains, we're talking about an increase of approximately 3,300,000%! Riding Buffett's coattails has long been a profitable venture.\nAs we push into the fourth quarter, five Warren Buffett stocks look particularly attractive and can confidently be bought hand over fist by investors.\n\nBerkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.\nGeneral Motors\nOne of the best deals long-term investors are going to find in Berkshire Hathaway's portfolio at the moment is auto stock General Motors (NYSE:GM).\nLike most automakers, GM has had to contend with two big hurdles over the past 18 months. First, the pandemic caused consumers to scale back on major purchases, which reduced short-term auto sales at the dealership level. And second, supply chain issues in the wake of the pandemic have caused GM and other automakers to lower or halt production on certain models. While these concerns are tangible, they're not a long-term worry. This means whatever short-term pain General Motors is experiencing is an opportunity for patient investors to pounce.\nThe real excitement for GM has to do with the electrification of consumer and enterprise auto fleets. In an effort to combat climate change, we're liable to see a multi-decade vehicle replacement cycle that almost exclusively emphasizes electric-powered vehicles. For its part, General Motors is investing $35 billion in electric vehicle (EVs), autonomous vehicle, and battery research through 2025. By mid-decade, the company expects to have launched 30 new EVs globally.\nWhile General Motors has long been a key player in its home market, the U.S., it's no slouch in the world's biggest auto market, either. GM is on pace to sell about 3 million vehicles in China this year (based on sales through the first six months), and has the deep pockets and infrastructure capable of gobbling up EV market share in the world's second-largest economy by gross domestic product.\nLong story short, a forward price-to-earnings (P/E) ratio of 8 no longer makes sense for a company whose growth rate could sustainably pick up for decades.\n\nImage source: Getty Images.\nBristol Myers Squibb\nValue stocks have always been a big theme for Warren Buffett, and that's exactly what investors are going to get with pharmaceutical stock Bristol Myers Squibb (NYSE:BMY).\nLike most healthcare stocks, Bristol Myers' products are highly defensive. This is to say that a stock market decline or even an economic contraction won't adversely affect demand for its pharmaceuticals. Since we don't get to choose when we get sick or what ailment(s) we develop, drugmakers like Bristol Myers usually offer highly predictable cash flow.\nOne company-specific reason investors can buy this Warren Buffett stock hand over fist for the fourth quarter is its organic growth opportunity. Eliquis, which was developed with Pfizer, has become the most-popular oral anticoagulant in the world and should bring in more than $10 billion in sales for Bristol Myers Squibb this year. There's also cancer immunotherapy Opdivo, which I believe offers even more long-term opportunity. Although Opdivo flamed out in advanced lung cancer trials a few years back, it's being examined in dozens of clinical trials and has a very good chance to generate billions in added annual revenue via label expansion opportunities.\nBristol Myers' acquisition of cancer and immunology drugmaker Celgene in late 2019 gets high marks, too. Buying Celgene brought multiple myeloma drug Revlimid into Bristol's portfolio. Revlimid brought in over $12 billion in sales last year, and has a track record of maintaining double-digit annual sales growth. This key therapy is protected from an onslaught of generic competition until the end of January 2026.\nThere aren't many better values right now than Bristol Myers Squibb at less than 8 times Wall Street's forward-year earnings forecast.\n\nImage source: Getty Images.\nTeva Pharmaceutical Industries\nIn terms of valuation, no Warren Buffett stock is cheaper than brand-name and generic-drug company Teva Pharmaceutical Industries (NYSE:TEVA). Shares of the company can be scooped up by investors right now for under 4 times forecasted earnings per share in 2021.\nHow does a profitable company in a defensive sector get pushed to such a low multiple? The truth is Teva has had a lot of things go wrong over the past five years. It overpaid for generic-drug company Actavis, which ballooned its debt, and it's found itself in the crosshairs of litigation on more than one occasion. In fact, most U.S. states are litigating against Teva regarding its role in opioid crisis. The uncertainty surrounding these cases is primarily responsible for keeping Teva's valuation in check.\nThankfully, Teva has a secret weapon: CEO Kare Schultz. Schultz was hired in late 2017 as a turnaround specialist, and through nearly four years with the company he's worked wonders. Billions in annual operating expenses have been shed, and the company's net debt has shrunk from more than $34 billion when he took over to less than $24 billion. At the current trajectory, Teva could have around $15 billion in net debt by the end of 2023.\nWhat's more, Schultz has the acumen to work out settlements for Teva's remaining legal issues. Considering Teva's debt position, Schultz is angling to offer free or discounted products, rather than pay cash. With most other drugmakers settling their opioid lawsuits, it seems to be just a matter of time before this gray cloud clears up and Teva returns to a fair valuation multiple.\n\nImage source: Getty Images.\nVisa and Mastercard\nThe final two Warren Buffett stocks to buy hand over fist for the fourth quarter are being lumped together for good reason: They're chief competitors and two of the most dominant companies in the payment-processing landscape, Visa (NYSE:V) and Mastercard (NYSE:MA).\nThe reason Visa and Mastercard have performed so well for so long is because they're cyclically tied companies. Although economic contractions and recessions are inevitable, they usually only last for a few months to a couple of quarters. Comparatively, periods of economic expansion last years. Payment processors Visa and Mastercard are simply benefiting from these disproportionately longer periods of expansion.\nThis dynamic duo also outperforms because they strictly stick to payment processing and aren't direct lenders. While it could be argued that they're giving up the opportunity to generate interest income and fees during these long-winded expansions, they're also shielded from a rise in credit delinquencies during economic contractions and recessions. Not having to set aside capital to cover credit delinquencies is a big reason why their profit margins remain so consistently high.\nThere's also a long runway for organic expansion with both companies. Most global transactions are still be conducted in cash, and a number of regions are remain underbanked (e.g., Southeastern Asia, the Middle East, and Africa). Pushing their payment infrastructure into these regions should allow Visa and Mastercard to sustain high single-digit sales growth for a long time to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829700221,"gmtCreate":1633541759168,"gmtModify":1633541759443,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829700221","repostId":"2173917919","repostType":4,"repost":{"id":"2173917919","pubTimestamp":1633524180,"share":"https://www.laohu8.com/m/news/2173917919?lang=&edition=full","pubTime":"2021-10-06 20:43","market":"us","language":"en","title":"Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2173917919","media":"Motley Fool","summary":"A certain type of investment is on the rise Wednesday morning.","content":"<p>Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes were poised to lose substantial ground when the market opens. In premarket trading Wednesday morning as of 8 a.m. EDT, futures on the <b>Dow Jones Industrial Average </b>(DJINDICES:^DJI) were down 326 points to 33,857. Futures on the <b>S&P 500 </b>(SNPINDEX:^GSPC) dropped 48 points to 4,286, and <b>Nasdaq Composite </b>(NASDAQINDEX:^IXIC) futures fell 186 points to 14,470.</p>\n<p>Stock market volatility levels have been on the rise, and many investors are looking to protect themselves against further declines by looking to the options market. A key measure of volatility, the <b>CBOE Volatility Index </b>(VOLATILITYINDICES:^VIX), has seen a couple of its biggest spikes all year come in the last couple of weeks. That has some investors looking for ways to profit -- and this morning, they're turning to exchange-traded funds designed to try to track the VIX.</p>\n<p><img src=\"https://static.tigerbbs.com/22719786dce6b2278c6f4132a5bc86ff\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Volatility ETFs and the VIX</h3>\n<p>The ETF universe has found ways to invest in nearly anything, and volatility is no exception. Because there's no way to invest directly in movements in the VIX, volatility ETFs concentrate on VIX futures contracts.</p>\n<p>One relatively simple exchange-traded volatility product is <b>iPath Series B S&P 500 VIX Short-Term Futures </b>(NYSEMKT:VXX). This security is designed to track the daily movements in the front month and second month VIX futures contracts. Given this morning's rise in anticipated volatility, shares of the iPath volatility product are up more than 4% in pre-market trading.</p>\n<p>A similar product is <b>ProShares VIX Short-Term Futures ETF </b>(NYSEMKT:VIXY). It uses a slightly different methodology in selecting futures contracts to achieve the same goal. It's also up nearly 4% as of 8 a.m. EDT Wednesday.</p>\n<p>Those investors seeking an even larger gain from rising volatility levels can use leveraged volatility ETFs. The <b>ProShares Ultra VIX Short-Term Futures ETF </b>(NYSEMKT:UVXY) offers moves that are 1.5 times the corresponding daily movement of various VIX futures contracts. That multiple has the ProShares fund up nearly 6% in the pre-market session Wednesday.</p>\n<h3>The dangers of volatility ETFs</h3>\n<p>Investing in volatility is dangerous. The first thing to keep in mind is that these products are all designed to tie to <i>daily </i>returns, and that makes them less than ideal for long-term investors. For instance, looking at the iPath's history, it lost money every single year from 2009 to 2017, eked out a tiny positive return in 2018, lost two-thirds of its value in 2019, and climbed just 11% in 2020's turbulent stock market year. It's down more than 60% so far in 2021.</p>\n<p>However, the massive returns you can earn if you have perfect timing are tempting. From mid-February to mid-March in 2020, the iPath product jumped more than 320%. The ProShares Ultra volatility ETF gained nearly 700%. But you do have to have perfect timing on both ends -- by the end of April 2020, the funds had given back 50% to 60% of those gains. By the end of the year, the ProShares fund had actually dropped back to a net loss after its huge spike.</p>\n<p>Because of their big daily moves, volatility ETFs are attractive to short-term traders. For long-term investors, though, the better way to play volatility is to have cash on hand to buy attractive stocks when they're cheap after a downswing. The bargains you'll reap can end up being top performers in your portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks Set to Fall Again: Is This the Secret to Making Money When Markets Plunge?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-06 20:43 GMT+8 <a href=https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TVIX":"二倍做多VIX波动率指数短期期权ETN","UVXY":"1.5倍做多波动率指数短期期货ETF-ProShares","VXX":"短期VIX期货ETN","VIXY":"波动率短期期货指数ETF","SVXY":"0.5倍做空波动率指数短期期货ETF"},"source_url":"https://www.fool.com/investing/2021/10/06/stocks-fall-again-secret-make-money-market-plunge/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173917919","content_text":"Wall Street has been extremely turbulent lately, and on Wednesday morning, investors got another case of the jitters. Focusing on all the things that could go wrong in the market, major stock indexes were poised to lose substantial ground when the market opens. In premarket trading Wednesday morning as of 8 a.m. EDT, futures on the Dow Jones Industrial Average (DJINDICES:^DJI) were down 326 points to 33,857. Futures on the S&P 500 (SNPINDEX:^GSPC) dropped 48 points to 4,286, and Nasdaq Composite (NASDAQINDEX:^IXIC) futures fell 186 points to 14,470.\nStock market volatility levels have been on the rise, and many investors are looking to protect themselves against further declines by looking to the options market. A key measure of volatility, the CBOE Volatility Index (VOLATILITYINDICES:^VIX), has seen a couple of its biggest spikes all year come in the last couple of weeks. That has some investors looking for ways to profit -- and this morning, they're turning to exchange-traded funds designed to try to track the VIX.\n\nImage source: Getty Images.\nVolatility ETFs and the VIX\nThe ETF universe has found ways to invest in nearly anything, and volatility is no exception. Because there's no way to invest directly in movements in the VIX, volatility ETFs concentrate on VIX futures contracts.\nOne relatively simple exchange-traded volatility product is iPath Series B S&P 500 VIX Short-Term Futures (NYSEMKT:VXX). This security is designed to track the daily movements in the front month and second month VIX futures contracts. Given this morning's rise in anticipated volatility, shares of the iPath volatility product are up more than 4% in pre-market trading.\nA similar product is ProShares VIX Short-Term Futures ETF (NYSEMKT:VIXY). It uses a slightly different methodology in selecting futures contracts to achieve the same goal. It's also up nearly 4% as of 8 a.m. EDT Wednesday.\nThose investors seeking an even larger gain from rising volatility levels can use leveraged volatility ETFs. The ProShares Ultra VIX Short-Term Futures ETF (NYSEMKT:UVXY) offers moves that are 1.5 times the corresponding daily movement of various VIX futures contracts. That multiple has the ProShares fund up nearly 6% in the pre-market session Wednesday.\nThe dangers of volatility ETFs\nInvesting in volatility is dangerous. The first thing to keep in mind is that these products are all designed to tie to daily returns, and that makes them less than ideal for long-term investors. For instance, looking at the iPath's history, it lost money every single year from 2009 to 2017, eked out a tiny positive return in 2018, lost two-thirds of its value in 2019, and climbed just 11% in 2020's turbulent stock market year. It's down more than 60% so far in 2021.\nHowever, the massive returns you can earn if you have perfect timing are tempting. From mid-February to mid-March in 2020, the iPath product jumped more than 320%. The ProShares Ultra volatility ETF gained nearly 700%. But you do have to have perfect timing on both ends -- by the end of April 2020, the funds had given back 50% to 60% of those gains. By the end of the year, the ProShares fund had actually dropped back to a net loss after its huge spike.\nBecause of their big daily moves, volatility ETFs are attractive to short-term traders. For long-term investors, though, the better way to play volatility is to have cash on hand to buy attractive stocks when they're cheap after a downswing. The bargains you'll reap can end up being top performers in your portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864160263,"gmtCreate":1633074817584,"gmtModify":1633074817856,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864160263","repostId":"2172951249","repostType":4,"repost":{"id":"2172951249","pubTimestamp":1633063493,"share":"https://www.laohu8.com/m/news/2172951249?lang=&edition=full","pubTime":"2021-10-01 12:44","market":"us","language":"en","title":"Billionaire Bill Ackman is smoking 'mentor' Warren Buffett with these income stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2172951249","media":"MoneyWise","summary":"Dividend stocks might look boring, but they can provide exciting returns.\nJust ask famed activist in","content":"<p><img src=\"https://static.tigerbbs.com/968262da7f9e673173261c3b2753bbcd\" tg-width=\"1800\" tg-height=\"800\" referrerpolicy=\"no-referrer\"></p>\n<p>Dividend stocks might look boring, but they can provide exciting returns.</p>\n<p>Just ask famed activist investor and self-proclaimed Warren Buffett acolyte Bill Ackman.</p>\n<p>His hedge fund Pershing Square Holdings has delivered annualized total returns of more than 30% over the last three years, substantially outperforming the S&P 500 and even Buffett’s own Berkshire Hathaway.</p>\n<p>And he did it largely by owning dividend stocks.</p>\n<p>According to Pershing’s latest 13F filing with the Securities Exchange Commission, nearly 60% of its holdings by market value are invested in dividend stocks.</p>\n<p>Let’s take a look at three stocks in Ackman’s portfolio that regulary dish out cash to investors — <a href=\"https://laohu8.com/S/AONE.U\">one</a> of them could be worth buying with your spare change.</p>\n<h2><a href=\"https://laohu8.com/S/QSR\">Restaurant Brands International Inc</a> (QSR)</h2>\n<p><img src=\"https://static.tigerbbs.com/ab0e3bda7c2635779ea2e4385b71b4f5\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">Tony Prato/Shutterstock</p>\n<p>Leading off the list is Restaurant Brands International, a fast-food holding company formed in 2014 by the merger between Burger King and Canadian coffee chain <a href=\"https://laohu8.com/S/THI\">Tim Hortons</a>.</p>\n<p>In 2017, the company added Popeyes Louisiana Kitchen to its portfolio.</p>\n<p>Like most restaurant stocks, Restaurant Brands shares tumbled during the pandemic-induced market sell-off in early 2020. But the stock has since made a strong recovery.</p>\n<p>That rebound is backed by substantial improvements in the company’s business. According to the latest earnings report, same-store sales — a key measure of a retailer’s health — increased 27.6%.</p>\n<p>Adjusted earnings came in at $0.77 per share for the quarter, more than double the $0.33 per share it earned in the year-ago period. The amount also covered the company’s quarterly dividend payment of $0.53 per share with ease.</p>\n<p>Restaurant Brands is offering a healthy annual dividend yield of 3.4%, which is a return investors can earn even if they're investing with spare nickels and dimes.</p>\n<p>For comparison, that’s a higher yield than fast-food restaurant giants McDonald’s (2.26%), Starbucks (1.6%), and Yum! Brands (1.6%).</p>\n<h2>Lowe’s Companies Inc (LOW)</h2>\n<p><img src=\"https://static.tigerbbs.com/9156dee5d6fe15d87a22b5b32ec030c4\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">Ken Wolter/Shutterstock</p>\n<p>Lowe’s is Bill Ackman’s largest holding by market value, and the position has served the billionaire investor quite well.</p>\n<p>Shares of the home improvement retail giant are up 29% year to date. The S&P 500 has returned 16% over the same period.</p>\n<p>What’s more impressive than Lowe’s near-term stock price performance is how the company’s dividend has grown over the years.</p>\n<p>The economy moves in cycles, but Lowe’s payout has only gone up. In fact, the company has increased its payout to shareholders every year for the past 59 years.</p>\n<p>Decades of dividend hikes has brought Lowe’s quarterly dividend to $0.80 per share, translating to an annual yield of 1.5%.</p>\n<p>Note that its competitors are also dividend-paying companies: Home Depot yields 2.0%, Target pays 1.5%, while Walmart offers an annual yield of 1.6%.</p>\n<p>Due to Lowe’s rally over the past year, its shares now trade at over $200. But you can get a piece of the company using a popular stock trading app that allows you to buy fractions of shares with as much money as you’re willing to spend.</p>\n<h2>Agilent Technologies Inc (A)</h2>\n<p><img src=\"https://static.tigerbbs.com/bb79764fc5df837d32b32e674c6d4ec9\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">Elnur/Shutterstock</p>\n<p>Agilent isn’t a household name, but within its own industry, the company is a force to be reckoned with.</p>\n<p>Agilent provides bio-analyitical and electronic measurement solutions to a wide variety of industries including communications, life sciences, and chemical analysis.</p>\n<p>Headquartered in Santa Clara, Calif., the company’s products are used by 265,000 labs around the world. In Agilent’s fiscal 2020, it brought in $5.34 billion of total revenue.</p>\n<p>And in the most recent quarter, revenue grew 26% year-over-year to $1.59 billion.</p>\n<p>Given this kind of performance, you’d think Agilent shares would be soaring. But while the stock has returned a solid 60% over the past year, it has pulled back about 10% since the peak in early September.</p>\n<p>On the dividend front, Agilent offers an annual yield of 0.5%, which may not seem like much. But the company has an excellent track record when it comes to returning cash to investors: Since 2014, Agilent’s per share quarterly payout has increased by 106%.</p>\n<h2>Rental income stream?</h2>\n<p>The neat thing with dividend stocks is that they provide a way for investors to earn a steady income stream regardless of what the economy is doing.</p>\n<p>Of course, you don’t have to limit yourself to the stock market to do that.</p>\n<p>For instance, one investing service makes it possible to lock in a steady rental income stream by investing in premium real estate properties — from commercial developments in LA to residential buildings in NYC.</p>\n<p>You’ll gain exposure to high-end properties that big-time real estate moguls usually have access to, and you’ll receive regular payouts in the form of quarterly dividend distributions.</p>\n<p><i>This article provides information only and should not be construed as advice. It is provided without warranty of any kind.</i></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Billionaire Bill Ackman is smoking 'mentor' Warren Buffett with these income stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBillionaire Bill Ackman is smoking 'mentor' Warren Buffett with these income stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 12:44 GMT+8 <a href=https://finance.yahoo.com/news/billionaire-bill-ackman-smoking-mentor-201900070.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks might look boring, but they can provide exciting returns.\nJust ask famed activist investor and self-proclaimed Warren Buffett acolyte Bill Ackman.\nHis hedge fund Pershing Square ...</p>\n\n<a href=\"https://finance.yahoo.com/news/billionaire-bill-ackman-smoking-mentor-201900070.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WMT":"沃尔玛","LOW":"劳氏","YUM":"百胜餐饮集团","SBUX":"星巴克","A":"安捷伦科技","MCD":"麦当劳","QSR":"餐饮品牌国际","TGT":"塔吉特","HD":"家得宝"},"source_url":"https://finance.yahoo.com/news/billionaire-bill-ackman-smoking-mentor-201900070.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2172951249","content_text":"Dividend stocks might look boring, but they can provide exciting returns.\nJust ask famed activist investor and self-proclaimed Warren Buffett acolyte Bill Ackman.\nHis hedge fund Pershing Square Holdings has delivered annualized total returns of more than 30% over the last three years, substantially outperforming the S&P 500 and even Buffett’s own Berkshire Hathaway.\nAnd he did it largely by owning dividend stocks.\nAccording to Pershing’s latest 13F filing with the Securities Exchange Commission, nearly 60% of its holdings by market value are invested in dividend stocks.\nLet’s take a look at three stocks in Ackman’s portfolio that regulary dish out cash to investors — one of them could be worth buying with your spare change.\nRestaurant Brands International Inc (QSR)\nTony Prato/Shutterstock\nLeading off the list is Restaurant Brands International, a fast-food holding company formed in 2014 by the merger between Burger King and Canadian coffee chain Tim Hortons.\nIn 2017, the company added Popeyes Louisiana Kitchen to its portfolio.\nLike most restaurant stocks, Restaurant Brands shares tumbled during the pandemic-induced market sell-off in early 2020. But the stock has since made a strong recovery.\nThat rebound is backed by substantial improvements in the company’s business. According to the latest earnings report, same-store sales — a key measure of a retailer’s health — increased 27.6%.\nAdjusted earnings came in at $0.77 per share for the quarter, more than double the $0.33 per share it earned in the year-ago period. The amount also covered the company’s quarterly dividend payment of $0.53 per share with ease.\nRestaurant Brands is offering a healthy annual dividend yield of 3.4%, which is a return investors can earn even if they're investing with spare nickels and dimes.\nFor comparison, that’s a higher yield than fast-food restaurant giants McDonald’s (2.26%), Starbucks (1.6%), and Yum! Brands (1.6%).\nLowe’s Companies Inc (LOW)\nKen Wolter/Shutterstock\nLowe’s is Bill Ackman’s largest holding by market value, and the position has served the billionaire investor quite well.\nShares of the home improvement retail giant are up 29% year to date. The S&P 500 has returned 16% over the same period.\nWhat’s more impressive than Lowe’s near-term stock price performance is how the company’s dividend has grown over the years.\nThe economy moves in cycles, but Lowe’s payout has only gone up. In fact, the company has increased its payout to shareholders every year for the past 59 years.\nDecades of dividend hikes has brought Lowe’s quarterly dividend to $0.80 per share, translating to an annual yield of 1.5%.\nNote that its competitors are also dividend-paying companies: Home Depot yields 2.0%, Target pays 1.5%, while Walmart offers an annual yield of 1.6%.\nDue to Lowe’s rally over the past year, its shares now trade at over $200. But you can get a piece of the company using a popular stock trading app that allows you to buy fractions of shares with as much money as you’re willing to spend.\nAgilent Technologies Inc (A)\nElnur/Shutterstock\nAgilent isn’t a household name, but within its own industry, the company is a force to be reckoned with.\nAgilent provides bio-analyitical and electronic measurement solutions to a wide variety of industries including communications, life sciences, and chemical analysis.\nHeadquartered in Santa Clara, Calif., the company’s products are used by 265,000 labs around the world. In Agilent’s fiscal 2020, it brought in $5.34 billion of total revenue.\nAnd in the most recent quarter, revenue grew 26% year-over-year to $1.59 billion.\nGiven this kind of performance, you’d think Agilent shares would be soaring. But while the stock has returned a solid 60% over the past year, it has pulled back about 10% since the peak in early September.\nOn the dividend front, Agilent offers an annual yield of 0.5%, which may not seem like much. But the company has an excellent track record when it comes to returning cash to investors: Since 2014, Agilent’s per share quarterly payout has increased by 106%.\nRental income stream?\nThe neat thing with dividend stocks is that they provide a way for investors to earn a steady income stream regardless of what the economy is doing.\nOf course, you don’t have to limit yourself to the stock market to do that.\nFor instance, one investing service makes it possible to lock in a steady rental income stream by investing in premium real estate properties — from commercial developments in LA to residential buildings in NYC.\nYou’ll gain exposure to high-end properties that big-time real estate moguls usually have access to, and you’ll receive regular payouts in the form of quarterly dividend distributions.\nThis article provides information only and should not be construed as advice. It is provided without warranty of any kind.","news_type":1},"isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865108666,"gmtCreate":1632959230203,"gmtModify":1632959230459,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865108666","repostId":"2171115602","repostType":4,"repost":{"id":"2171115602","pubTimestamp":1632935460,"share":"https://www.laohu8.com/m/news/2171115602?lang=&edition=full","pubTime":"2021-09-30 01:11","market":"us","language":"en","title":"Eyewear maker Warby Parker spikes 34% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2171115602","media":"MarketWatch","summary":"Eyewear maker Warby Parker spikes 34% on its first day of trading.\n\nNYSE assigns reference price of ","content":"<p>Eyewear maker Warby Parker spikes 34% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/f145f99950734ec9b0e3b675836a53fb\" tg-width=\"1836\" tg-height=\"901\" referrerpolicy=\"no-referrer\"></p>\n<p>NYSE assigns reference price of $40, trading to begin Wednesday</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5917e3b384716a3bbcfdd5860b35711f\" tg-width=\"700\" tg-height=\"628\" referrerpolicy=\"no-referrer\"><span>Warby Parker is focused on both business and giving back, the prospectus says.</span></p>\n<p><a href=\"https://laohu8.com/S/WRBY\">Warby Parker Inc.</a>, the company known for its affordable eyeglasses sold online, through its app and in stores, is begining trading Wednesday in a direct listing.</p>\n<p>On Tuesday, the New York Stock Exchange assigned a $40 reference price to the New York City-based company's listing, which is expected to begin trading Wednesday under the ticker symbol \"WRBY\" . The company has about 111.5 million shares outstanding, giving it a valuation around $4.6 billion at that reference price.</p>\n<p>Reference prices for direct listings are based on trading prices in private markets ahead of companies filing with the Securities and Exchange Commission for a public listing. Direct listings differ from IPOs because there is no capital raised, which is what places a dollar figure on shares in an IPO. Direct listings are largely expected to trade higher than the reference price.</p>\n<p>Warby Parker will offer class A stock, eligible for one vote per share; class B stock, which entitles shareholders to 10 votes per share and can be converted to class A shares; and class C shares, which carry no voting rights.</p>\n<p>Warby Parker will be an emerging growth company, which means it does not have to make the same disclosures required of bigger public companies. A business remains an emerging growth company until it reaches a number of milestones, including annual revenue of more than $1.07 billion.</p>\n<p>Neil Blumenthal and Dave Gilboa, ages 41 and 40 respectively, are co-founders, co-chairs and co-chief executives of the company.</p>\n<p>Prior to Warby Parker, Blumenthal was a director at VisionSpring, a nonprofit that trains men and women in developing countries to sell affordable eyewear. Blumenthal is also a director at Allbirds, which filed to go public this week, at salad chain Sweetgreen and a number of nonprofit organizations including Warby Parker Impact Foundation and RxArt.</p>\n<p>Gilboa worked at consulting firm Bain & Company and merchant bank Allen & Co. prior to Warby Parker. He also serves on the board of the Warby Parker Impact Foundation.</p>\n<p>Andrew Hunt and Jeffrey Raider, both age 40, are the other two co-founders of Warby Parker and both serve as directors. Also on the board is Ronald Williams, age 71, and former CEO of Aetna from 2006 to 2010.</p>\n<p>Warby Parker was founded in 2010 and inspired by the founders' concerns that glasses were expensive and the process of buying them inconvenient.</p>\n<p>In its prospectus, Warby Parker says it is driven to do good and make customers happy. In addition to making glasses more affordable, Warby Parker has distributed more than 8 million pairs of glasses through the Buy a Pair, Give a Pair program. The company is also carbon neutral, which it has achieved through purchasing offsets.</p>\n<p>\"[This motivation] pushes us to defy convention -- and, at times, to forego short-term profits -- but we believe delivering remarkable customer experiences and making a positive impact on all stakeholders will lead to continued long-term sustainable growth and profitability,\" says a letter from the co-CEOs included in the prospectus.</p>\n<p>A pair of Warby Parker spectacles starts at a price of $95 including prescription lenses, and can be purchased digitally, using a free home try-on system or virtual trial system, as well as at145 Warby Parker shops. The company keeps prices low by selling direct-to-consumer and bypassing middlemen.</p>\n<p>The company had a net loss of $55.9 million in 2020, after breakeven in 2019 and a loss of $22.9 million in 2018. It chalked up $393.7 million of revenue in 2020, up from $370.5 million in 2019.</p>\n<p>Some 95% of net revenue in 2020 came from the sale of glasses, 2% of revenue was generated by the sale of contact lenses, 1% by eye exams and 2% by eyewear accessories. The company is expecting to expand its customer base for eye exams.</p>\n<p>For the six months ending June 30, 2021, net losses were $7.3 million and revenue totaled $270.5 million. The company has more than two million active customers and nearly 3,000 workers.</p>\n<p><img src=\"https://static.tigerbbs.com/3510dd6c717e636f33784d4f89bd9ce3\" tg-width=\"506\" tg-height=\"706\" referrerpolicy=\"no-referrer\"></p>\n<p>About 76% of Americans were using some kind of vision correction in 2020, according to data provided by the prospectus. The number of Americans ages 65 and over will more than double over the next 40 years and at least 84% of people in this older age group wear corrective lenses. Increasing use of screens like mobile devices and computers has contributed to the need for vision correction. Glasses are replaced every two-to-two-and-a-half years.</p>\n<p>Warby Parker says that between 2015 and 2019, it had a 50% sales retention rate within two years of the first purchase among customers it acquired. The retention rate was nearly 100% after four years during that same period.</p>\n<p>The vision care industry is expected to grow at a 9.2% compound annual growth rate (CAGR) between 2020 and 2025, according to Statista data provided in the prospectus.</p>\n<p>Here are five other things to know about Warby Parker before it goes public:</p>\n<p><b>Most decision-making power will be in the hands of Warby Parker's co-founders and co-CEOs</b></p>\n<p>The company's stock structure post-IPO will give the company's founders and top executives considerable control that could last until Oct. 1, 2031.</p>\n<p>\"Because of the ten-to-one voting ratio between our class B and class A common stock, our co-founders and co-CEOs collectively could continue to control a significant percentage of the combined voting power of our common stock and therefore would be able to control all matters submitted to our stockholders for approval until the date of automatic conversion, when all shares outstanding of Class B common stock will convert automatically into shares of Class A common stock,\" the prospectus says.</p>\n<p>That means other shareholders will have little say in the running of the company and will not influence such decisions as the election of directors, amendments of organizational documents, and any merger, consolidation, or sale of some or all of its assets.</p>\n<p>As a loss-making company, it will not pay a dividend for the foreseeable future.</p>\n<p><b>Warby Parker does most things in-house -- and that could limit its ability to grow</b></p>\n<p>Warby Parker says its business model, which has it do most things in-house, could cause problems.</p>\n<p>\"[T]he vertically integrated nature of our business, where we design all of our own glasses in our New York headquarters, contract manufacture all of our glass frames, fulfill the glasses we sell at our own optical and fulfillment laboratories as well as at third-party contract laboratories, sell our products exclusively through our own retail stores, e-commerce site and mobile application, and service our products, exposes us to risk and disruption at many points that are critical to successfully operating our business, and may make it more difficult for us to scale our business,\" the prospectus says.</p>\n<p><b>Supply chain troubles outside of those caused by COVID-19 could arise</b></p>\n<p>Supply chain problems have plagued companies across the consumer space this year. But the company warns that its operations are vulnerable to other challenges as well.</p>\n<p>Warby Parker gets more than half of the cellulose acetate used in its frames from a single supplier. Other components are sourced from the U.S., China, Italy, Vietnam, and Japan. The company also uses third-party contractors on certain items, but doesn't have long-term contracts with these suppliers.</p>\n<p>\"We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or modify components used in our products,\" the prospectus says.</p>\n<p>\"We may in the future experience component shortages, and the predictability of the availability of these components may be limited, which may be heightened in light of the ongoing COVID-19 pandemic.\"</p>\n<p><b>Warby Parker says customers are slow to adopt e-commerce for eyeglasses</b></p>\n<p>Warby Parker offers online shopping for eyeglasses, one of the most significant ways the company differentiates itself from a crowded competitive field. But the company says many customers are more comfortable shopping for eyeglasses in person.</p>\n<p>\"Improving upon the consumer in-store experience through an online platform is difficult due to broad consumer demands on selection, quality, convenience, and affordability,\" the prospectus says.</p>\n<p>When the company first started, less than 2.5% of glasses were purchased online. Even now, the company says it has \"historically generated a significant portion of our revenue from our retail stores, and our growth strategy will depend, in large part, on acquiring customers through the growth of our retail store base and expansion of our existing retail store operations.\"</p>\n<p><b>Warby Parker's business is actually seasonal</b></p>\n<p>Customers eager to use health benefits before the end of a calendar year tend to boost demand in December.</p>\n<p>\"Consistent with our policy to recognize revenue upon order delivery, any orders placed at the end of December are recognized as revenue upon delivery which may occur in the following year,\" Warby Parker said.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eyewear maker Warby Parker spikes 34% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEyewear maker Warby Parker spikes 34% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 01:11 GMT+8 <a href=https://www.marketwatch.com/story/warby-parker-ipo-5-things-to-know-about-the-affordable-eyeglass-maker-before-its-direct-listing-11630520146?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Eyewear maker Warby Parker spikes 34% on its first day of trading.\n\nNYSE assigns reference price of $40, trading to begin Wednesday\nWarby Parker is focused on both business and giving back, the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/warby-parker-ipo-5-things-to-know-about-the-affordable-eyeglass-maker-before-its-direct-listing-11630520146?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/warby-parker-ipo-5-things-to-know-about-the-affordable-eyeglass-maker-before-its-direct-listing-11630520146?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171115602","content_text":"Eyewear maker Warby Parker spikes 34% on its first day of trading.\n\nNYSE assigns reference price of $40, trading to begin Wednesday\nWarby Parker is focused on both business and giving back, the prospectus says.\nWarby Parker Inc., the company known for its affordable eyeglasses sold online, through its app and in stores, is begining trading Wednesday in a direct listing.\nOn Tuesday, the New York Stock Exchange assigned a $40 reference price to the New York City-based company's listing, which is expected to begin trading Wednesday under the ticker symbol \"WRBY\" . The company has about 111.5 million shares outstanding, giving it a valuation around $4.6 billion at that reference price.\nReference prices for direct listings are based on trading prices in private markets ahead of companies filing with the Securities and Exchange Commission for a public listing. Direct listings differ from IPOs because there is no capital raised, which is what places a dollar figure on shares in an IPO. Direct listings are largely expected to trade higher than the reference price.\nWarby Parker will offer class A stock, eligible for one vote per share; class B stock, which entitles shareholders to 10 votes per share and can be converted to class A shares; and class C shares, which carry no voting rights.\nWarby Parker will be an emerging growth company, which means it does not have to make the same disclosures required of bigger public companies. A business remains an emerging growth company until it reaches a number of milestones, including annual revenue of more than $1.07 billion.\nNeil Blumenthal and Dave Gilboa, ages 41 and 40 respectively, are co-founders, co-chairs and co-chief executives of the company.\nPrior to Warby Parker, Blumenthal was a director at VisionSpring, a nonprofit that trains men and women in developing countries to sell affordable eyewear. Blumenthal is also a director at Allbirds, which filed to go public this week, at salad chain Sweetgreen and a number of nonprofit organizations including Warby Parker Impact Foundation and RxArt.\nGilboa worked at consulting firm Bain & Company and merchant bank Allen & Co. prior to Warby Parker. He also serves on the board of the Warby Parker Impact Foundation.\nAndrew Hunt and Jeffrey Raider, both age 40, are the other two co-founders of Warby Parker and both serve as directors. Also on the board is Ronald Williams, age 71, and former CEO of Aetna from 2006 to 2010.\nWarby Parker was founded in 2010 and inspired by the founders' concerns that glasses were expensive and the process of buying them inconvenient.\nIn its prospectus, Warby Parker says it is driven to do good and make customers happy. In addition to making glasses more affordable, Warby Parker has distributed more than 8 million pairs of glasses through the Buy a Pair, Give a Pair program. The company is also carbon neutral, which it has achieved through purchasing offsets.\n\"[This motivation] pushes us to defy convention -- and, at times, to forego short-term profits -- but we believe delivering remarkable customer experiences and making a positive impact on all stakeholders will lead to continued long-term sustainable growth and profitability,\" says a letter from the co-CEOs included in the prospectus.\nA pair of Warby Parker spectacles starts at a price of $95 including prescription lenses, and can be purchased digitally, using a free home try-on system or virtual trial system, as well as at145 Warby Parker shops. The company keeps prices low by selling direct-to-consumer and bypassing middlemen.\nThe company had a net loss of $55.9 million in 2020, after breakeven in 2019 and a loss of $22.9 million in 2018. It chalked up $393.7 million of revenue in 2020, up from $370.5 million in 2019.\nSome 95% of net revenue in 2020 came from the sale of glasses, 2% of revenue was generated by the sale of contact lenses, 1% by eye exams and 2% by eyewear accessories. The company is expecting to expand its customer base for eye exams.\nFor the six months ending June 30, 2021, net losses were $7.3 million and revenue totaled $270.5 million. The company has more than two million active customers and nearly 3,000 workers.\n\nAbout 76% of Americans were using some kind of vision correction in 2020, according to data provided by the prospectus. The number of Americans ages 65 and over will more than double over the next 40 years and at least 84% of people in this older age group wear corrective lenses. Increasing use of screens like mobile devices and computers has contributed to the need for vision correction. Glasses are replaced every two-to-two-and-a-half years.\nWarby Parker says that between 2015 and 2019, it had a 50% sales retention rate within two years of the first purchase among customers it acquired. The retention rate was nearly 100% after four years during that same period.\nThe vision care industry is expected to grow at a 9.2% compound annual growth rate (CAGR) between 2020 and 2025, according to Statista data provided in the prospectus.\nHere are five other things to know about Warby Parker before it goes public:\nMost decision-making power will be in the hands of Warby Parker's co-founders and co-CEOs\nThe company's stock structure post-IPO will give the company's founders and top executives considerable control that could last until Oct. 1, 2031.\n\"Because of the ten-to-one voting ratio between our class B and class A common stock, our co-founders and co-CEOs collectively could continue to control a significant percentage of the combined voting power of our common stock and therefore would be able to control all matters submitted to our stockholders for approval until the date of automatic conversion, when all shares outstanding of Class B common stock will convert automatically into shares of Class A common stock,\" the prospectus says.\nThat means other shareholders will have little say in the running of the company and will not influence such decisions as the election of directors, amendments of organizational documents, and any merger, consolidation, or sale of some or all of its assets.\nAs a loss-making company, it will not pay a dividend for the foreseeable future.\nWarby Parker does most things in-house -- and that could limit its ability to grow\nWarby Parker says its business model, which has it do most things in-house, could cause problems.\n\"[T]he vertically integrated nature of our business, where we design all of our own glasses in our New York headquarters, contract manufacture all of our glass frames, fulfill the glasses we sell at our own optical and fulfillment laboratories as well as at third-party contract laboratories, sell our products exclusively through our own retail stores, e-commerce site and mobile application, and service our products, exposes us to risk and disruption at many points that are critical to successfully operating our business, and may make it more difficult for us to scale our business,\" the prospectus says.\nSupply chain troubles outside of those caused by COVID-19 could arise\nSupply chain problems have plagued companies across the consumer space this year. But the company warns that its operations are vulnerable to other challenges as well.\nWarby Parker gets more than half of the cellulose acetate used in its frames from a single supplier. Other components are sourced from the U.S., China, Italy, Vietnam, and Japan. The company also uses third-party contractors on certain items, but doesn't have long-term contracts with these suppliers.\n\"We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or modify components used in our products,\" the prospectus says.\n\"We may in the future experience component shortages, and the predictability of the availability of these components may be limited, which may be heightened in light of the ongoing COVID-19 pandemic.\"\nWarby Parker says customers are slow to adopt e-commerce for eyeglasses\nWarby Parker offers online shopping for eyeglasses, one of the most significant ways the company differentiates itself from a crowded competitive field. But the company says many customers are more comfortable shopping for eyeglasses in person.\n\"Improving upon the consumer in-store experience through an online platform is difficult due to broad consumer demands on selection, quality, convenience, and affordability,\" the prospectus says.\nWhen the company first started, less than 2.5% of glasses were purchased online. Even now, the company says it has \"historically generated a significant portion of our revenue from our retail stores, and our growth strategy will depend, in large part, on acquiring customers through the growth of our retail store base and expansion of our existing retail store operations.\"\nWarby Parker's business is actually seasonal\nCustomers eager to use health benefits before the end of a calendar year tend to boost demand in December.\n\"Consistent with our policy to recognize revenue upon order delivery, any orders placed at the end of December are recognized as revenue upon delivery which may occur in the following year,\" Warby Parker said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865096452,"gmtCreate":1632922485825,"gmtModify":1632922507602,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"like pls","listText":"like pls","text":"like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865096452","repostId":"1136349988","repostType":4,"repost":{"id":"1136349988","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632922319,"share":"https://www.laohu8.com/m/news/1136349988?lang=&edition=full","pubTime":"2021-09-29 21:31","market":"us","language":"en","title":"Stocks rebound slightly as 10-year yield’s run takes a breather","url":"https://stock-news.laohu8.com/highlight/detail?id=1136349988","media":"Tiger Newspress","summary":"U.S. stocks were slightly higher Wednesday as the rapid increase in the 10-year Treasury yield coole","content":"<p>U.S. stocks were slightly higher Wednesday as the rapid increase in the 10-year Treasury yield cooled, leading investors to buy some beaten-up tech stocks on the dip.</p>\n<p>The Dow Jones Industrial Average rose 114 points, or 0.3%. The S&P 500 futures gained 0.4%, and the tech-heavy Nasdaq Composite was the early leader with a gain of 0.4%. On Tuesday, the Nasdaq Composite posted its worst day since March amid a spike in bond yields.</p>\n<p><img src=\"https://static.tigerbbs.com/d6fbdcb02d3f8b96723665596b43f50c\" tg-width=\"1063\" tg-height=\"475\" referrerpolicy=\"no-referrer\"></p>\n<p>The 10-year Treasury Treasury yield eased slightly on Wednesday to trade right near 1.52%. The yield touched a high of 1.567% Tuesday.</p>\n<p>Tech stocks led Tuesday's rout with Facebook, Microsoft and Alphabet losing more than 3%. Amazon fell more than 2%. Rising bond yields can hurt growth stocks, including tech stocks, because they lower the relative value of future earnings and can make the shares look overvalued.</p>\n<p>But tech stocks were rebounding in Wednesday's early trading. Facebook, Amazon, Apple and Alphabet all rose. Zoom Video added more than 1%.</p>\n<p>Shares of the semiconductor company Micron fell more than 3% after it reported earnings and revenue outlook for the first quarter of 2022 that missed consensus estimates.</p>\n<p>\"If interest rate increases moderate from here on the back of declining inflation expectations, then it wouldn't surprise me to see the market resume its march higher as we move into the fourth quarter,\" said Brian Price, head of investment management for Commonwealth Financial Network.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rebound slightly as 10-year yield’s run takes a breather</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rebound slightly as 10-year yield’s run takes a breather\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-29 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks were slightly higher Wednesday as the rapid increase in the 10-year Treasury yield cooled, leading investors to buy some beaten-up tech stocks on the dip.</p>\n<p>The Dow Jones Industrial Average rose 114 points, or 0.3%. The S&P 500 futures gained 0.4%, and the tech-heavy Nasdaq Composite was the early leader with a gain of 0.4%. On Tuesday, the Nasdaq Composite posted its worst day since March amid a spike in bond yields.</p>\n<p><img src=\"https://static.tigerbbs.com/d6fbdcb02d3f8b96723665596b43f50c\" tg-width=\"1063\" tg-height=\"475\" referrerpolicy=\"no-referrer\"></p>\n<p>The 10-year Treasury Treasury yield eased slightly on Wednesday to trade right near 1.52%. The yield touched a high of 1.567% Tuesday.</p>\n<p>Tech stocks led Tuesday's rout with Facebook, Microsoft and Alphabet losing more than 3%. Amazon fell more than 2%. Rising bond yields can hurt growth stocks, including tech stocks, because they lower the relative value of future earnings and can make the shares look overvalued.</p>\n<p>But tech stocks were rebounding in Wednesday's early trading. Facebook, Amazon, Apple and Alphabet all rose. Zoom Video added more than 1%.</p>\n<p>Shares of the semiconductor company Micron fell more than 3% after it reported earnings and revenue outlook for the first quarter of 2022 that missed consensus estimates.</p>\n<p>\"If interest rate increases moderate from here on the back of declining inflation expectations, then it wouldn't surprise me to see the market resume its march higher as we move into the fourth quarter,\" said Brian Price, head of investment management for Commonwealth Financial Network.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136349988","content_text":"U.S. stocks were slightly higher Wednesday as the rapid increase in the 10-year Treasury yield cooled, leading investors to buy some beaten-up tech stocks on the dip.\nThe Dow Jones Industrial Average rose 114 points, or 0.3%. The S&P 500 futures gained 0.4%, and the tech-heavy Nasdaq Composite was the early leader with a gain of 0.4%. On Tuesday, the Nasdaq Composite posted its worst day since March amid a spike in bond yields.\n\nThe 10-year Treasury Treasury yield eased slightly on Wednesday to trade right near 1.52%. The yield touched a high of 1.567% Tuesday.\nTech stocks led Tuesday's rout with Facebook, Microsoft and Alphabet losing more than 3%. Amazon fell more than 2%. Rising bond yields can hurt growth stocks, including tech stocks, because they lower the relative value of future earnings and can make the shares look overvalued.\nBut tech stocks were rebounding in Wednesday's early trading. Facebook, Amazon, Apple and Alphabet all rose. Zoom Video added more than 1%.\nShares of the semiconductor company Micron fell more than 3% after it reported earnings and revenue outlook for the first quarter of 2022 that missed consensus estimates.\n\"If interest rate increases moderate from here on the back of declining inflation expectations, then it wouldn't surprise me to see the market resume its march higher as we move into the fourth quarter,\" said Brian Price, head of investment management for Commonwealth Financial Network.","news_type":1},"isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862328722,"gmtCreate":1632838744829,"gmtModify":1632838783100,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Why?","listText":"Why?","text":"Why?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862328722","repostId":"1193693996","repostType":4,"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868560763,"gmtCreate":1632672667552,"gmtModify":1632798652732,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls! ","listText":"Like pls! ","text":"Like pls!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/868560763","repostId":"1175726457","repostType":4,"repost":{"id":"1175726457","pubTimestamp":1632626757,"share":"https://www.laohu8.com/m/news/1175726457?lang=&edition=full","pubTime":"2021-09-26 11:25","market":"sh","language":"en","title":"Opinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell","url":"https://stock-news.laohu8.com/highlight/detail?id=1175726457","media":"Market Watch","summary":"It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for tw","content":"<p>It’s an urgent question, since the <a href=\"https://laohu8.com/S/C\">Citigroup</a> Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the extent to which the latest economic news deviates from the Wall Street consensus. The past two months of consistently negative CESI readings therefore mean that the economic news, on balance, has been worse than expected.</p>\n<p>Is it good news or bad for stock investors that recent U.S. economic news releases have been significantly worse than expected?</p>\n<p>The latest reading from the Citigroup Economic Surprise Index (CESI) is minus 29.2. <a href=\"https://laohu8.com/S/JE\">Just</a> 10 days ago it was even more negative, at minus 61.7. Its average over the last 18 years is 4.6.</p>\n<p><img src=\"https://static.tigerbbs.com/dd20c01571a824c8113089a65b814bb3\" tg-width=\"700\" tg-height=\"471\" referrerpolicy=\"no-referrer\"></p>\n<p>There is no consensus among the advisers I monitor about what these latest readings mean. Some believe it’s good news, on the contrarian theory that the worse-than-expected news constitutes a“wall of worry”that the U.S. bull market can climb. Others argue that you can’t sugar-coat worse-than-expected economic news.</p>\n<p>To help resolve their disagreement, I analyzed daily CESI data back to 2003. Specifically, I measured its correlation with the S&P 500’sSPX,+0.15%return over the subsequent month-, quarter-, six months, and <a href=\"https://laohu8.com/S/AONE.U\">one</a> year. I came up with nothing that met traditional standards of statistical significance.</p>\n<p>A summary of what I found is plotted in the chart below. Notice that the S&P 500’s average return is virtually the same regardless of whether the CESI is positive or negative, trending upward or downward.</p>\n<p><img src=\"https://static.tigerbbs.com/65016b28c482526ac92a5d6035ba9ed9\" tg-width=\"700\" tg-height=\"471\" referrerpolicy=\"no-referrer\"></p>\n<p>These findings are not a criticism of the CESI itself. Citigroup created the index as a useful tool for foreign exchange traders.Citigroup has saidthat the CESI “is a perfect example of unique proprietary design which has almost no bearing on those who discuss it… It was not meant to be used for stock prices.”</p>\n<p>There’s a broader lesson here for us to learn as well: We need to subject our intuitions to empirical reality checks. That’s especially important when our hunches seem so obviously true — as is the case when it comes to whether the economic news is coming in better or worse than expected. Stock market history is filled with expectations that were guaranteed to happen but which did not.</p>\n<p>It can be tedious plowing through huge databases to see if a pattern really exists. But it’s worth the effort. Though being statistically rigorous does not guarantee that you will beat the market, you most assuredly will lose to the market if you’re statistically sloppy and inconsistent.</p>","source":"lsy1616996754749","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-26 11:25 GMT+8 <a href=https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page><strong>Market Watch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175726457","content_text":"It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the extent to which the latest economic news deviates from the Wall Street consensus. The past two months of consistently negative CESI readings therefore mean that the economic news, on balance, has been worse than expected.\nIs it good news or bad for stock investors that recent U.S. economic news releases have been significantly worse than expected?\nThe latest reading from the Citigroup Economic Surprise Index (CESI) is minus 29.2. Just 10 days ago it was even more negative, at minus 61.7. Its average over the last 18 years is 4.6.\n\nThere is no consensus among the advisers I monitor about what these latest readings mean. Some believe it’s good news, on the contrarian theory that the worse-than-expected news constitutes a“wall of worry”that the U.S. bull market can climb. Others argue that you can’t sugar-coat worse-than-expected economic news.\nTo help resolve their disagreement, I analyzed daily CESI data back to 2003. Specifically, I measured its correlation with the S&P 500’sSPX,+0.15%return over the subsequent month-, quarter-, six months, and one year. I came up with nothing that met traditional standards of statistical significance.\nA summary of what I found is plotted in the chart below. Notice that the S&P 500’s average return is virtually the same regardless of whether the CESI is positive or negative, trending upward or downward.\n\nThese findings are not a criticism of the CESI itself. Citigroup created the index as a useful tool for foreign exchange traders.Citigroup has saidthat the CESI “is a perfect example of unique proprietary design which has almost no bearing on those who discuss it… It was not meant to be used for stock prices.”\nThere’s a broader lesson here for us to learn as well: We need to subject our intuitions to empirical reality checks. That’s especially important when our hunches seem so obviously true — as is the case when it comes to whether the economic news is coming in better or worse than expected. Stock market history is filled with expectations that were guaranteed to happen but which did not.\nIt can be tedious plowing through huge databases to see if a pattern really exists. But it’s worth the effort. Though being statistically rigorous does not guarantee that you will beat the market, you most assuredly will lose to the market if you’re statistically sloppy and inconsistent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861215210,"gmtCreate":1632497498530,"gmtModify":1632715722942,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls!!","listText":"Like pls!!","text":"Like pls!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861215210","repostId":"1142559059","repostType":4,"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":865096452,"gmtCreate":1632922485825,"gmtModify":1632922507602,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"like pls","listText":"like pls","text":"like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865096452","repostId":"1136349988","repostType":4,"isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868560763,"gmtCreate":1632672667552,"gmtModify":1632798652732,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls! ","listText":"Like pls! ","text":"Like pls!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/868560763","repostId":"1175726457","repostType":4,"repost":{"id":"1175726457","pubTimestamp":1632626757,"share":"https://www.laohu8.com/m/news/1175726457?lang=&edition=full","pubTime":"2021-09-26 11:25","market":"sh","language":"en","title":"Opinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell","url":"https://stock-news.laohu8.com/highlight/detail?id=1175726457","media":"Market Watch","summary":"It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for tw","content":"<p>It’s an urgent question, since the <a href=\"https://laohu8.com/S/C\">Citigroup</a> Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the extent to which the latest economic news deviates from the Wall Street consensus. The past two months of consistently negative CESI readings therefore mean that the economic news, on balance, has been worse than expected.</p>\n<p>Is it good news or bad for stock investors that recent U.S. economic news releases have been significantly worse than expected?</p>\n<p>The latest reading from the Citigroup Economic Surprise Index (CESI) is minus 29.2. <a href=\"https://laohu8.com/S/JE\">Just</a> 10 days ago it was even more negative, at minus 61.7. Its average over the last 18 years is 4.6.</p>\n<p><img src=\"https://static.tigerbbs.com/dd20c01571a824c8113089a65b814bb3\" tg-width=\"700\" tg-height=\"471\" referrerpolicy=\"no-referrer\"></p>\n<p>There is no consensus among the advisers I monitor about what these latest readings mean. Some believe it’s good news, on the contrarian theory that the worse-than-expected news constitutes a“wall of worry”that the U.S. bull market can climb. Others argue that you can’t sugar-coat worse-than-expected economic news.</p>\n<p>To help resolve their disagreement, I analyzed daily CESI data back to 2003. Specifically, I measured its correlation with the S&P 500’sSPX,+0.15%return over the subsequent month-, quarter-, six months, and <a href=\"https://laohu8.com/S/AONE.U\">one</a> year. I came up with nothing that met traditional standards of statistical significance.</p>\n<p>A summary of what I found is plotted in the chart below. Notice that the S&P 500’s average return is virtually the same regardless of whether the CESI is positive or negative, trending upward or downward.</p>\n<p><img src=\"https://static.tigerbbs.com/65016b28c482526ac92a5d6035ba9ed9\" tg-width=\"700\" tg-height=\"471\" referrerpolicy=\"no-referrer\"></p>\n<p>These findings are not a criticism of the CESI itself. Citigroup created the index as a useful tool for foreign exchange traders.Citigroup has saidthat the CESI “is a perfect example of unique proprietary design which has almost no bearing on those who discuss it… It was not meant to be used for stock prices.”</p>\n<p>There’s a broader lesson here for us to learn as well: We need to subject our intuitions to empirical reality checks. That’s especially important when our hunches seem so obviously true — as is the case when it comes to whether the economic news is coming in better or worse than expected. Stock market history is filled with expectations that were guaranteed to happen but which did not.</p>\n<p>It can be tedious plowing through huge databases to see if a pattern really exists. But it’s worth the effort. Though being statistically rigorous does not guarantee that you will beat the market, you most assuredly will lose to the market if you’re statistically sloppy and inconsistent.</p>","source":"lsy1616996754749","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpinion: Market analysts can’t agree on where stocks are going next. So double-check the data before you buy or sell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-26 11:25 GMT+8 <a href=https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page><strong>Market Watch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/market-analysts-cant-agree-on-where-stocks-are-going-next-so-double-check-the-data-before-you-buy-or-sell-11632447577?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175726457","content_text":"It’s an urgent question, since the Citigroup Economic Surprise Index (CESI) has been negative for two months now, following an unbroken positive stretch for more than a year. The CESI measures the extent to which the latest economic news deviates from the Wall Street consensus. The past two months of consistently negative CESI readings therefore mean that the economic news, on balance, has been worse than expected.\nIs it good news or bad for stock investors that recent U.S. economic news releases have been significantly worse than expected?\nThe latest reading from the Citigroup Economic Surprise Index (CESI) is minus 29.2. Just 10 days ago it was even more negative, at minus 61.7. Its average over the last 18 years is 4.6.\n\nThere is no consensus among the advisers I monitor about what these latest readings mean. Some believe it’s good news, on the contrarian theory that the worse-than-expected news constitutes a“wall of worry”that the U.S. bull market can climb. Others argue that you can’t sugar-coat worse-than-expected economic news.\nTo help resolve their disagreement, I analyzed daily CESI data back to 2003. Specifically, I measured its correlation with the S&P 500’sSPX,+0.15%return over the subsequent month-, quarter-, six months, and one year. I came up with nothing that met traditional standards of statistical significance.\nA summary of what I found is plotted in the chart below. Notice that the S&P 500’s average return is virtually the same regardless of whether the CESI is positive or negative, trending upward or downward.\n\nThese findings are not a criticism of the CESI itself. Citigroup created the index as a useful tool for foreign exchange traders.Citigroup has saidthat the CESI “is a perfect example of unique proprietary design which has almost no bearing on those who discuss it… It was not meant to be used for stock prices.”\nThere’s a broader lesson here for us to learn as well: We need to subject our intuitions to empirical reality checks. That’s especially important when our hunches seem so obviously true — as is the case when it comes to whether the economic news is coming in better or worse than expected. Stock market history is filled with expectations that were guaranteed to happen but which did not.\nIt can be tedious plowing through huge databases to see if a pattern really exists. But it’s worth the effort. Though being statistically rigorous does not guarantee that you will beat the market, you most assuredly will lose to the market if you’re statistically sloppy and inconsistent.","news_type":1},"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864160263,"gmtCreate":1633074817584,"gmtModify":1633074817856,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864160263","repostId":"2172951249","repostType":4,"isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":822215628,"gmtCreate":1634134333390,"gmtModify":1634134333485,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/822215628","repostId":"1155202922","repostType":4,"isVote":1,"tweetType":1,"viewCount":610,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859825606,"gmtCreate":1634688403387,"gmtModify":1634688403667,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls!!","listText":"Like pls!!","text":"Like pls!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859825606","repostId":"2176710436","repostType":4,"isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":827030112,"gmtCreate":1634364716783,"gmtModify":1634364717065,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/827030112","repostId":"2175146556","repostType":4,"repost":{"id":"2175146556","pubTimestamp":1634328035,"share":"https://www.laohu8.com/m/news/2175146556?lang=&edition=full","pubTime":"2021-10-16 04:00","market":"us","language":"en","title":"Wall St ends higher as Goldman rounds out parade of strong bank results","url":"https://stock-news.laohu8.com/highlight/detail?id=2175146556","media":"Reuters","summary":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news","content":"<p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)</p>\n<ul>\n <li>Retail sales up 0.7% in September despite shortages</li>\n <li>Goldman Sachs rises on strong third-quarter earnings (New throughout, updates prices, market activity and comments to close)</li>\n</ul>\n<p>NEW YORK, Oct 15 (Reuters) - U.S. stocks ended higher on Friday after Goldman Sachs became the latest big bank to report strong quarterly earnings, and Wall Street's three major indexes posted gains for the week.</p>\n<p>Goldman Sachs Group shares jumped, giving the Dow its biggest boost, as a record wave of dealmaking activity drove a surge in the bank's quarterly profit.</p>\n<p>Other big lenders also rose and were among the biggest positive for the S&P 500. The index's bank index ended sharply higher.</p>\n<p>Results from the big financial institutions this week have provided a strong start to third-quarter U.S. earnings, though investors will still watch in coming weeks for signs of impacts from supply chain disruptions and higher costs, especially for energy.</p>\n<p>Forecasts now call for S&P 500 earnings to show a 32% rise in the third quarter from a year ago. The latest forecast, based on results from 41 of the S&P 500 companies and estimates for the rest, is up from 29.4% at the start of October, according to IBES data from Refinitiv.</p>\n<p>\"We're starting to get into an earnings-driven rally here that I hope lasts. We'll really see the results in the next couple of weeks as a great bulk of companies in all sectors report,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Alcoa Corp shares surged after the aluminum producer reported stronger-than-expected results, announced a $500 million buyback program and initiated a quarterly cash dividend.</p>\n<p>According to preliminary data, the S&P 500 gained 33.35 points, or 0.75%, to end at 4,471.61 points, while the Nasdaq Composite gained 73.55 points, or 0.50%, to 14,896.98. The Dow Jones Industrial Average rose 384.83 points, or 1.10%, to 35,297.39.</p>\n<p>The U.S. Commerce Department reported a surprise rise in retail sales in September, although investors still worried that supply constraints could disrupt the holiday shopping season. A preliminary reading for consumer sentiment in October came in slightly below expectations.</p>\n<p>Some airline and other travel-related company shares edged higher, with the White House announcing it will lift travel restrictions for fully-vaccinated foreign nationals effective Nov. 8.</p>\n<p>Moderna Inc shares were lower. A Wall Street Journal report, citing people familiar with the matter, said the U.S. Food and Drug Administration is delaying its decision on authorizing Moderna's COVID-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation.</p>\n<p>On Thursday, an FDA panel voted to recommend booster shots of its COVID-19 vaccine for Americans aged 65 and older and high-risk people.</p>\n<p>Shares of cryptocurrency and blockchain-related firms including Riot Blockchain gained as bitcoin hit $60,000 for the first time since April. (Additional reporting by Devik Jain in Bengaluru and Federica Urso in Gdansk; Editing by Anil D'Silva, Arun Koyyur and Nick Zieminski)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends higher as Goldman rounds out parade of strong bank results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends higher as Goldman rounds out parade of strong bank results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-16 04:00 GMT+8 <a href=https://finance.yahoo.com/news/us-stocks-wall-st-ends-200035041.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)\n\nRetail sales up 0.7% in September despite shortages\nGoldman Sachs rises on strong third-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-ends-200035041.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COMP":"Compass, Inc.","GS":"高盛","GSBD":"高盛BDC基金"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-ends-200035041.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2175146556","content_text":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)\n\nRetail sales up 0.7% in September despite shortages\nGoldman Sachs rises on strong third-quarter earnings (New throughout, updates prices, market activity and comments to close)\n\nNEW YORK, Oct 15 (Reuters) - U.S. stocks ended higher on Friday after Goldman Sachs became the latest big bank to report strong quarterly earnings, and Wall Street's three major indexes posted gains for the week.\nGoldman Sachs Group shares jumped, giving the Dow its biggest boost, as a record wave of dealmaking activity drove a surge in the bank's quarterly profit.\nOther big lenders also rose and were among the biggest positive for the S&P 500. The index's bank index ended sharply higher.\nResults from the big financial institutions this week have provided a strong start to third-quarter U.S. earnings, though investors will still watch in coming weeks for signs of impacts from supply chain disruptions and higher costs, especially for energy.\nForecasts now call for S&P 500 earnings to show a 32% rise in the third quarter from a year ago. The latest forecast, based on results from 41 of the S&P 500 companies and estimates for the rest, is up from 29.4% at the start of October, according to IBES data from Refinitiv.\n\"We're starting to get into an earnings-driven rally here that I hope lasts. We'll really see the results in the next couple of weeks as a great bulk of companies in all sectors report,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.\nAlcoa Corp shares surged after the aluminum producer reported stronger-than-expected results, announced a $500 million buyback program and initiated a quarterly cash dividend.\nAccording to preliminary data, the S&P 500 gained 33.35 points, or 0.75%, to end at 4,471.61 points, while the Nasdaq Composite gained 73.55 points, or 0.50%, to 14,896.98. The Dow Jones Industrial Average rose 384.83 points, or 1.10%, to 35,297.39.\nThe U.S. Commerce Department reported a surprise rise in retail sales in September, although investors still worried that supply constraints could disrupt the holiday shopping season. A preliminary reading for consumer sentiment in October came in slightly below expectations.\nSome airline and other travel-related company shares edged higher, with the White House announcing it will lift travel restrictions for fully-vaccinated foreign nationals effective Nov. 8.\nModerna Inc shares were lower. A Wall Street Journal report, citing people familiar with the matter, said the U.S. Food and Drug Administration is delaying its decision on authorizing Moderna's COVID-19 vaccine for adolescents to check if the shot could increase the risk of heart inflammation.\nOn Thursday, an FDA panel voted to recommend booster shots of its COVID-19 vaccine for Americans aged 65 and older and high-risk people.\nShares of cryptocurrency and blockchain-related firms including Riot Blockchain gained as bitcoin hit $60,000 for the first time since April. (Additional reporting by Devik Jain in Bengaluru and Federica Urso in Gdansk; Editing by Anil D'Silva, Arun Koyyur and Nick Zieminski)","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826044916,"gmtCreate":1633961213185,"gmtModify":1633961213298,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls!!","listText":"Like pls!!","text":"Like pls!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/826044916","repostId":"1180287437","repostType":4,"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829700221,"gmtCreate":1633541759168,"gmtModify":1633541759443,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829700221","repostId":"2173917919","repostType":4,"isVote":1,"tweetType":1,"viewCount":419,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862328722,"gmtCreate":1632838744829,"gmtModify":1632838783100,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Why?","listText":"Why?","text":"Why?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862328722","repostId":"1193693996","repostType":4,"repost":{"id":"1193693996","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632836938,"share":"https://www.laohu8.com/m/news/1193693996?lang=&edition=full","pubTime":"2021-09-28 21:48","market":"us","language":"en","title":"Pharmaceutical stocks slid in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693996","media":"Tiger Newspress","summary":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca f","content":"<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca fell between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks slid in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks slid in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-28 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca fell between 1% and 7%.</p>\n<p><img src=\"https://static.tigerbbs.com/bc8af8822165a8a89dc1b54a9195f782\" tg-width=\"398\" tg-height=\"729\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REGN":"再生元制药公司","GILD":"吉利德科学","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","LLY":"礼来","MRNA":"Moderna, Inc.","PFE":"辉瑞","AZN":"阿斯利康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193693996","content_text":"Pharmaceutical stocks slid in morning trading.Pfizer,BioNTech SE,Eli Lilly,Moderna and AstraZeneca fell between 1% and 7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":825212577,"gmtCreate":1634227219177,"gmtModify":1634227219177,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/825212577","repostId":"1108820000","repostType":4,"isVote":1,"tweetType":1,"viewCount":249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861215210,"gmtCreate":1632497498530,"gmtModify":1632715722942,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls!!","listText":"Like pls!!","text":"Like pls!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861215210","repostId":"1142559059","repostType":4,"repost":{"id":"1142559059","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632484839,"share":"https://www.laohu8.com/m/news/1142559059?lang=&edition=full","pubTime":"2021-09-24 20:00","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1142559059","media":"Tiger Newspress","summary":"(Sept 24) Stock futures gave back gains after equities' best day since July.\nAt 08:01 a.m. ET, Dow e","content":"<p>(Sept 24) Stock futures gave back gains after equities' best day since July.</p>\n<p>At 08:01 a.m. ET, Dow e-minis were down 149 points, or 0.43%, S&P 500 e-minis fell 22.75 points, or 0.51%, and <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> 100 e-minis sank 106.5 points, or 0.70%.</p>\n<p><img src=\"https://static.tigerbbs.com/30a653559f88adfa0843eba93e9dc775\" tg-width=\"1242\" tg-height=\"493\" referrerpolicy=\"no-referrer\"></p>\n<p>Cryptocurrency-exposed stocks slumped in U.S. premarket trading. Marathon Digital (MARA) drops 6.5%, Bit Digital (BTBT) declines 4.7%, Riot Blockchain (RIOT) -5.9%, Coinbase -2.8%.</p>\n<p>Big banks including JPMorgan, Citigroup, Morgan Stanley and Bank of America Corp slipped about 0.5%, while oil majors Exxon Mobil and Chevron Corp were down 0.4% and 0.3%, respectively, in premarket trading.Mega-cap FAAMG tech giants fell between 0.5% and 0.6%. Nike shed 4.6% after the sportswear maker cut its fiscal 2022 sales expectations and warned of delays during the holiday shopping season. Several analysts lowered their price targets on the maker of sports apparel and sneakers after the company cut its FY revenue growth guidance to mid-single- digits.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p>Robinhood(HOOD),Coinbase(COIN) -- Shares of the retail trading app and cryptocurrency exchange fell in premarket trading after China signaled that it was intensifying its crackdown on crypto.The country's central bank said Friday that all cryptocurrency-related activities are illegal. Shares of Coinbase fell more than 3.6% while Robinhood dropped 2%.</p>\n<p>Roku(ROKU) — Shares of the streaming video platform fell in premarket trading afterWells Fargo downgraded Roku to equal weight from overweight. The investment firm said in a note that Wall Street expectations for Roku's revenue growth are likely too high as competition increases. Shares of Roku were down 2.3%.</p>\n<p>Nike(NKE) — The apparel giant’s stock was under pressure on Friday afterNike cut its revenue forecasts due to supply chain issues.The company said it expects full-year sales growth in the mid-single digits for the 2022 fiscal year, down from a previous forecast of low double-digit growth. Shares of Nike fell more than 4% in premarket trading.</p>\n<p>Under Armour(UAA) — The athletic apparel retailer’s stock fell in premarket trading after rival Nike cut its guidance. Shares of Under Armour were down more than 2% in premarket trading.</p>\n<p>Costco(COST) — The retailer beat expectations on the top and bottom lines in its fiscal fourth-quarter report on Thursday afternoon. The company reported $3.90 in adjusted earnings per share, easily topping expectations of $3.57, and net sales for the quarter rose more than 17% year over year. The stock was slightly higher in premarket trading.</p>\n<p>Merck(MRK) — The pharmaceutical giant, along withAstraZeneca, announced on Friday morning that a treatment using the drug Lynparza slowed the progression of prostate cancer in a phase three trial. Shares of Merck rose more than 1% in premarket trading.</p>\n<p>Cheesecake Factory(CAKE),Dave & Buster's(PLAY) — The restaurant stocks rose slightly in premarket trading after Jefferies upgraded the stocks to buy from hold. The firm said that full-service restaurants have seen traffic hold up well despite the spread of the delta variant.</p>\n<p>Helbiz (HLBZ) — Helbiz falls 10% after the micromobility company filed with the SEC for the sale of as many as 11m shares by stockholders.</p>\n<p>Focus Universal (FCUV), — Focus Universal an online marketing company that’s been a favorite of retail traders, surged 26% in premarket trading after the stock was cited on Stocktwits in recent days.</p>\n<p>Vail Resorts (MTN) — Vail Resorts falls 2.7% in postmarket trading after its full-year forecasts for Ebitda and net income missed at the midpoint.</p>\n<p>GlycoMimetics (GLYC) — GlycoMimetics jumps 15% postmarket after announcing that efficacy and safety data from a Phase 1/2 study of uproleselan in patients with acute myeloid leukemia were published in the journal Blood on Sept. 16.</p>\n<p>VTV Therapeutics (VTVT) — VTV Therapeutics surges 30% after company says its HPP737 psoriasis treatment showed favorable safety and tolerability profile in a multiple ascending dose study. </p>\n<p><b>In FX, </b>the Bloomberg Dollar Spot Index climbed back from a one-week low as concern about possible contagion from Evergrande added to buying of the greenback based on the Federal Reserve tapering timeline signaled on Wednesday. NZD, AUD and CAD sit at the bottom of the G-10 scoreboard. ZAR and TRY are the weakest in EM FX. The pound fell after its rally on Thursday as investors looked ahead to BOE Governor Andrew Bailey’s sPeech next week about a possible interest-rate hike. Traders are betting that in a contest to raise borrowing costs first, the Bank of England will be the runaway winner over the Federal Reserve. The New Zealand and Aussie dollars led declines among Group-of-10 peers. The euro was trading flat, with a week full of events failing “to generate any clear directional move,” said ING analysts Francesco Pesole and Chris Turner. German IFO sentiment indeces will “provide extra indications about the area’s sentiment as businesses faced a combination of delta variant concerns and lingering supply disruptions”. The Norwegian krone is the best performing currency among G10 peers this week, with Thursday’s announcement from the Norges Bank offering support</p>\n<p><b>In commodities,</b> crude futures hold a narrow range up around best levels for the week. WTI stalls near $73.40, Brent near $77.50. Spot gold extends Asia’s gains, adding $12 on the session to trade near $1,755/oz. Base metals are mixed, LME nickel and aluminum drop ~1%, LME tin outperforms with a 2.8% rally. Bitcoin dips after the PBOC says all crypto-related transactions are illegal.</p>\n<p>Looking to the day ahead now, we’ll hear from Fed Chair Powell, Vice Chair Clarida and the Fed’s Mester, Bowman, George and Bostic, as well as the ECB’s Lane and Elderson, and the BoE’s Tenreyro. Finally, a summit of the Quad Leaders will be held at the White House, including President Biden, and the Prime Ministers of Australia, India and Japan.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-24 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 24) Stock futures gave back gains after equities' best day since July.</p>\n<p>At 08:01 a.m. ET, Dow e-minis were down 149 points, or 0.43%, S&P 500 e-minis fell 22.75 points, or 0.51%, and <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> 100 e-minis sank 106.5 points, or 0.70%.</p>\n<p><img src=\"https://static.tigerbbs.com/30a653559f88adfa0843eba93e9dc775\" tg-width=\"1242\" tg-height=\"493\" referrerpolicy=\"no-referrer\"></p>\n<p>Cryptocurrency-exposed stocks slumped in U.S. premarket trading. Marathon Digital (MARA) drops 6.5%, Bit Digital (BTBT) declines 4.7%, Riot Blockchain (RIOT) -5.9%, Coinbase -2.8%.</p>\n<p>Big banks including JPMorgan, Citigroup, Morgan Stanley and Bank of America Corp slipped about 0.5%, while oil majors Exxon Mobil and Chevron Corp were down 0.4% and 0.3%, respectively, in premarket trading.Mega-cap FAAMG tech giants fell between 0.5% and 0.6%. Nike shed 4.6% after the sportswear maker cut its fiscal 2022 sales expectations and warned of delays during the holiday shopping season. Several analysts lowered their price targets on the maker of sports apparel and sneakers after the company cut its FY revenue growth guidance to mid-single- digits.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p>Robinhood(HOOD),Coinbase(COIN) -- Shares of the retail trading app and cryptocurrency exchange fell in premarket trading after China signaled that it was intensifying its crackdown on crypto.The country's central bank said Friday that all cryptocurrency-related activities are illegal. Shares of Coinbase fell more than 3.6% while Robinhood dropped 2%.</p>\n<p>Roku(ROKU) — Shares of the streaming video platform fell in premarket trading afterWells Fargo downgraded Roku to equal weight from overweight. The investment firm said in a note that Wall Street expectations for Roku's revenue growth are likely too high as competition increases. Shares of Roku were down 2.3%.</p>\n<p>Nike(NKE) — The apparel giant’s stock was under pressure on Friday afterNike cut its revenue forecasts due to supply chain issues.The company said it expects full-year sales growth in the mid-single digits for the 2022 fiscal year, down from a previous forecast of low double-digit growth. Shares of Nike fell more than 4% in premarket trading.</p>\n<p>Under Armour(UAA) — The athletic apparel retailer’s stock fell in premarket trading after rival Nike cut its guidance. Shares of Under Armour were down more than 2% in premarket trading.</p>\n<p>Costco(COST) — The retailer beat expectations on the top and bottom lines in its fiscal fourth-quarter report on Thursday afternoon. The company reported $3.90 in adjusted earnings per share, easily topping expectations of $3.57, and net sales for the quarter rose more than 17% year over year. The stock was slightly higher in premarket trading.</p>\n<p>Merck(MRK) — The pharmaceutical giant, along withAstraZeneca, announced on Friday morning that a treatment using the drug Lynparza slowed the progression of prostate cancer in a phase three trial. Shares of Merck rose more than 1% in premarket trading.</p>\n<p>Cheesecake Factory(CAKE),Dave & Buster's(PLAY) — The restaurant stocks rose slightly in premarket trading after Jefferies upgraded the stocks to buy from hold. The firm said that full-service restaurants have seen traffic hold up well despite the spread of the delta variant.</p>\n<p>Helbiz (HLBZ) — Helbiz falls 10% after the micromobility company filed with the SEC for the sale of as many as 11m shares by stockholders.</p>\n<p>Focus Universal (FCUV), — Focus Universal an online marketing company that’s been a favorite of retail traders, surged 26% in premarket trading after the stock was cited on Stocktwits in recent days.</p>\n<p>Vail Resorts (MTN) — Vail Resorts falls 2.7% in postmarket trading after its full-year forecasts for Ebitda and net income missed at the midpoint.</p>\n<p>GlycoMimetics (GLYC) — GlycoMimetics jumps 15% postmarket after announcing that efficacy and safety data from a Phase 1/2 study of uproleselan in patients with acute myeloid leukemia were published in the journal Blood on Sept. 16.</p>\n<p>VTV Therapeutics (VTVT) — VTV Therapeutics surges 30% after company says its HPP737 psoriasis treatment showed favorable safety and tolerability profile in a multiple ascending dose study. </p>\n<p><b>In FX, </b>the Bloomberg Dollar Spot Index climbed back from a one-week low as concern about possible contagion from Evergrande added to buying of the greenback based on the Federal Reserve tapering timeline signaled on Wednesday. NZD, AUD and CAD sit at the bottom of the G-10 scoreboard. ZAR and TRY are the weakest in EM FX. The pound fell after its rally on Thursday as investors looked ahead to BOE Governor Andrew Bailey’s sPeech next week about a possible interest-rate hike. Traders are betting that in a contest to raise borrowing costs first, the Bank of England will be the runaway winner over the Federal Reserve. The New Zealand and Aussie dollars led declines among Group-of-10 peers. The euro was trading flat, with a week full of events failing “to generate any clear directional move,” said ING analysts Francesco Pesole and Chris Turner. German IFO sentiment indeces will “provide extra indications about the area’s sentiment as businesses faced a combination of delta variant concerns and lingering supply disruptions”. The Norwegian krone is the best performing currency among G10 peers this week, with Thursday’s announcement from the Norges Bank offering support</p>\n<p><b>In commodities,</b> crude futures hold a narrow range up around best levels for the week. WTI stalls near $73.40, Brent near $77.50. Spot gold extends Asia’s gains, adding $12 on the session to trade near $1,755/oz. Base metals are mixed, LME nickel and aluminum drop ~1%, LME tin outperforms with a 2.8% rally. Bitcoin dips after the PBOC says all crypto-related transactions are illegal.</p>\n<p>Looking to the day ahead now, we’ll hear from Fed Chair Powell, Vice Chair Clarida and the Fed’s Mester, Bowman, George and Bostic, as well as the ECB’s Lane and Elderson, and the BoE’s Tenreyro. Finally, a summit of the Quad Leaders will be held at the White House, including President Biden, and the Prime Ministers of Australia, India and Japan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142559059","content_text":"(Sept 24) Stock futures gave back gains after equities' best day since July.\nAt 08:01 a.m. ET, Dow e-minis were down 149 points, or 0.43%, S&P 500 e-minis fell 22.75 points, or 0.51%, and Nasdaq 100 e-minis sank 106.5 points, or 0.70%.\n\nCryptocurrency-exposed stocks slumped in U.S. premarket trading. Marathon Digital (MARA) drops 6.5%, Bit Digital (BTBT) declines 4.7%, Riot Blockchain (RIOT) -5.9%, Coinbase -2.8%.\nBig banks including JPMorgan, Citigroup, Morgan Stanley and Bank of America Corp slipped about 0.5%, while oil majors Exxon Mobil and Chevron Corp were down 0.4% and 0.3%, respectively, in premarket trading.Mega-cap FAAMG tech giants fell between 0.5% and 0.6%. Nike shed 4.6% after the sportswear maker cut its fiscal 2022 sales expectations and warned of delays during the holiday shopping season. Several analysts lowered their price targets on the maker of sports apparel and sneakers after the company cut its FY revenue growth guidance to mid-single- digits.\nStocks making the biggest moves premarket:\nRobinhood(HOOD),Coinbase(COIN) -- Shares of the retail trading app and cryptocurrency exchange fell in premarket trading after China signaled that it was intensifying its crackdown on crypto.The country's central bank said Friday that all cryptocurrency-related activities are illegal. Shares of Coinbase fell more than 3.6% while Robinhood dropped 2%.\nRoku(ROKU) — Shares of the streaming video platform fell in premarket trading afterWells Fargo downgraded Roku to equal weight from overweight. The investment firm said in a note that Wall Street expectations for Roku's revenue growth are likely too high as competition increases. Shares of Roku were down 2.3%.\nNike(NKE) — The apparel giant’s stock was under pressure on Friday afterNike cut its revenue forecasts due to supply chain issues.The company said it expects full-year sales growth in the mid-single digits for the 2022 fiscal year, down from a previous forecast of low double-digit growth. Shares of Nike fell more than 4% in premarket trading.\nUnder Armour(UAA) — The athletic apparel retailer’s stock fell in premarket trading after rival Nike cut its guidance. Shares of Under Armour were down more than 2% in premarket trading.\nCostco(COST) — The retailer beat expectations on the top and bottom lines in its fiscal fourth-quarter report on Thursday afternoon. The company reported $3.90 in adjusted earnings per share, easily topping expectations of $3.57, and net sales for the quarter rose more than 17% year over year. The stock was slightly higher in premarket trading.\nMerck(MRK) — The pharmaceutical giant, along withAstraZeneca, announced on Friday morning that a treatment using the drug Lynparza slowed the progression of prostate cancer in a phase three trial. Shares of Merck rose more than 1% in premarket trading.\nCheesecake Factory(CAKE),Dave & Buster's(PLAY) — The restaurant stocks rose slightly in premarket trading after Jefferies upgraded the stocks to buy from hold. The firm said that full-service restaurants have seen traffic hold up well despite the spread of the delta variant.\nHelbiz (HLBZ) — Helbiz falls 10% after the micromobility company filed with the SEC for the sale of as many as 11m shares by stockholders.\nFocus Universal (FCUV), — Focus Universal an online marketing company that’s been a favorite of retail traders, surged 26% in premarket trading after the stock was cited on Stocktwits in recent days.\nVail Resorts (MTN) — Vail Resorts falls 2.7% in postmarket trading after its full-year forecasts for Ebitda and net income missed at the midpoint.\nGlycoMimetics (GLYC) — GlycoMimetics jumps 15% postmarket after announcing that efficacy and safety data from a Phase 1/2 study of uproleselan in patients with acute myeloid leukemia were published in the journal Blood on Sept. 16.\nVTV Therapeutics (VTVT) — VTV Therapeutics surges 30% after company says its HPP737 psoriasis treatment showed favorable safety and tolerability profile in a multiple ascending dose study. \nIn FX, the Bloomberg Dollar Spot Index climbed back from a one-week low as concern about possible contagion from Evergrande added to buying of the greenback based on the Federal Reserve tapering timeline signaled on Wednesday. NZD, AUD and CAD sit at the bottom of the G-10 scoreboard. ZAR and TRY are the weakest in EM FX. The pound fell after its rally on Thursday as investors looked ahead to BOE Governor Andrew Bailey’s sPeech next week about a possible interest-rate hike. Traders are betting that in a contest to raise borrowing costs first, the Bank of England will be the runaway winner over the Federal Reserve. The New Zealand and Aussie dollars led declines among Group-of-10 peers. The euro was trading flat, with a week full of events failing “to generate any clear directional move,” said ING analysts Francesco Pesole and Chris Turner. German IFO sentiment indeces will “provide extra indications about the area’s sentiment as businesses faced a combination of delta variant concerns and lingering supply disruptions”. The Norwegian krone is the best performing currency among G10 peers this week, with Thursday’s announcement from the Norges Bank offering support\nIn commodities, crude futures hold a narrow range up around best levels for the week. WTI stalls near $73.40, Brent near $77.50. Spot gold extends Asia’s gains, adding $12 on the session to trade near $1,755/oz. Base metals are mixed, LME nickel and aluminum drop ~1%, LME tin outperforms with a 2.8% rally. Bitcoin dips after the PBOC says all crypto-related transactions are illegal.\nLooking to the day ahead now, we’ll hear from Fed Chair Powell, Vice Chair Clarida and the Fed’s Mester, Bowman, George and Bostic, as well as the ECB’s Lane and Elderson, and the BoE’s Tenreyro. Finally, a summit of the Quad Leaders will be held at the White House, including President Biden, and the Prime Ministers of Australia, India and Japan.","news_type":1},"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859022245,"gmtCreate":1634642052633,"gmtModify":1634642072315,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!! Up up!!","listText":"Nice!! Up up!!","text":"Nice!! Up up!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859022245","repostId":"1198851965","repostType":4,"repost":{"id":"1198851965","pubTimestamp":1634623112,"share":"https://www.laohu8.com/m/news/1198851965?lang=&edition=full","pubTime":"2021-10-19 13:58","market":"us","language":"en","title":"Tesla Q3: Blowout Possible Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1198851965","media":"Seeking Alpha","summary":"Summary\n\nQ3 street estimates seems rather low.\nMargin strength could lead to large beat.\nInvestors l","content":"<p><b>Summary</b></p>\n<ul>\n <li>Q3 street estimates seems rather low.</li>\n <li>Margin strength could lead to large beat.</li>\n <li>Investors looking for comments on supply chain issues.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5041f66900bbf640321835328ad686ba\" tg-width=\"1536\" tg-height=\"793\" width=\"100%\" height=\"auto\"><span>AdrianHancu/iStock Editorial via Getty Images</span></p>\n<p>All eyes will be on electric vehicle maker Tesla(NASDAQ:TSLA)as the company reports its third quarter results after the bell on Wednesday, October 20th. Recently, the company announced record production and deliveries for the quarter that smashed analyst expectations. However, street estimates for Q3 haven't risen as much as one might expect, which could lead to another blowout earnings report this week.</p>\n<p>For the period, preliminary deliveries of 241,300 beat street estimates by nearly 20,000 units. In Q2 of this year, the average revenue per vehicle delivered (including regulatory credit sales) was just under $50,700. If you basically round off, the math tells you that a beat of that size should equal about an extra billion dollars in revenue. Going into the report, the street was exactly at $13 billion for its Q3 average, but take a look at where we are now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2c6077ce9974face1a7cfbeabe2e93e0\" tg-width=\"640\" tg-height=\"73\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha analyst estimates page</span></p>\n<p>Despite the large deliveries beat, the street average hasn't even risen by $650 million, so the consensus seems to be a bit low right now. Additionally, the \"low\" estimate seems completely off base, as that would represent a decline over Q2's top line figure despite an extra roughly 40,000 deliveries. Don't forget, the sequential jump in Model S cash deliveries was around 6,000 units, which at an average selling price of $100,000 is an additional $600 million in revenue alone. Taking the low estimate out would increase the street average by $100 million. Unless there was some massive discounting going on or some prior period adjustment, any revenue estimates around or below $13 billion just don't seem logical.</p>\n<p>Model Y sales to Europe, more Model S sales (including the expensive Plaid), and a full quarter of price raises in the US should all be tailwinds. The standard range Y in China will provide somewhat of a headwind, along with a slightly stronger dollar in the quarter. However, Tesla may be able to potentially recognize hundreds of millions of dollars in deferred revenue related to its full self-driving feature as that program expanded a bit during the quarter. I also am projecting a $100 million sequential decline in credit sales.</p>\n<p>Perhaps the biggest question in the quarter will be margins. All of those price hikes, the mix of more Model Y and new Model S, and the ramp of production in China should be positives, potentially offsetting some or all supply chain or chip shortage inflation. In my base case, I'm assuming that total automotive gross margins increase by one percentage point, or a little more than half of the 190 basis points they jumped from Q1 to Q2. As I usually do, the table below shows a bear, base, and bull case, with dollar values in millions except per share amounts.</p>\n<p><img src=\"https://static.tigerbbs.com/9f864f8d975853337e47b5f88687b983\" tg-width=\"551\" tg-height=\"595\" width=\"100%\" height=\"auto\">I'm sure there will be critics who think I'm just trying to set a high bar so that Tesla cannot beat my base case. That is not true here, as on the revenue side I'm not even halfway between the street average and the high estimate on the street. On the bottom line, I'm not even calling for Tesla to beat by as much as it did in Q2 (47 cents). Also, using the average jump from Q2 to Q3 non-GAAP earnings per share over the past three years would put us a bit above $2 per share, and I'm still calling for a one handle there. For Tesla to miss estimates on the bottom line, gross margins would have to drop by about a percentage point sequentially. Even then, a little revenue upside or savings on the operating expense lines could still fuel a bottom line beat.</p>\n<p>The other major item investors will be watching for is an update on Tesla's production facilities. It appears that Shanghai 3/Y production is now greater than Fremont's, and the Berlin and Texas factories are still on track to open this year. The company needs these facilities to come online in the next few months if it wants to hit a 50% yearly growth rate for 2022, likely meaning over 1.3 million deliveries. Any Tesla-specific delays that linger meaningfully into the new year may also impact other new products (Semi, Cybertruck, new Roadster) that have already been delayed a bit, as well as allowing the competition to potentially steal some market share. In the past few days, Tesla removed the Cybertruck's specifications and prices from its website. This may have to do with surging commodity costs since that product was unveiled, and it likely means Tesla will raise prices when production finally starts.</p>\n<p>As for Tesla shares, they are currently in a very nice uptrend and have broken solidly above $800 after the Q3 delivery report. As the chart below shows, the 50-day moving average (pink line) has crossed back above its longer term counterpart (200-day in purple). The stock closed Friday less than $60 from its all-time high, so the only concern here might be that the earnings report could be the old \"buy the rumor, sell the news\" type of event.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3d6c847a0a536db8d53da68a6fbbbeac\" tg-width=\"640\" tg-height=\"245\" width=\"100%\" height=\"auto\"><span>Source: Yahoo! Finance</span></p>\n<p>Tesla is set to report Q3 earnings this week, and it would not surprise me if we see the company beat again. Given the sharp sequential rise in deliveries, the street seems a bit low with some of its estimates, and any margin increases would likely mean a significant bottom line beat. Investors will be looking for updates on production capacities, not only to see if Berlin and Texas are close to being ready, but to start thinking about how far over one million deliveries Tesla could get next year. It certainly will be interesting to see the stock's reaction afterwards, as the recent rally may mean investors are pricing in another big beat.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Q3: Blowout Possible Again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Q3: Blowout Possible Again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-19 13:58 GMT+8 <a href=https://seekingalpha.com/article/4460443-tesla-stock-blowout-q3-possible-again><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nQ3 street estimates seems rather low.\nMargin strength could lead to large beat.\nInvestors looking for comments on supply chain issues.\n\nAdrianHancu/iStock Editorial via Getty Images\nAll eyes ...</p>\n\n<a href=\"https://seekingalpha.com/article/4460443-tesla-stock-blowout-q3-possible-again\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4460443-tesla-stock-blowout-q3-possible-again","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198851965","content_text":"Summary\n\nQ3 street estimates seems rather low.\nMargin strength could lead to large beat.\nInvestors looking for comments on supply chain issues.\n\nAdrianHancu/iStock Editorial via Getty Images\nAll eyes will be on electric vehicle maker Tesla(NASDAQ:TSLA)as the company reports its third quarter results after the bell on Wednesday, October 20th. Recently, the company announced record production and deliveries for the quarter that smashed analyst expectations. However, street estimates for Q3 haven't risen as much as one might expect, which could lead to another blowout earnings report this week.\nFor the period, preliminary deliveries of 241,300 beat street estimates by nearly 20,000 units. In Q2 of this year, the average revenue per vehicle delivered (including regulatory credit sales) was just under $50,700. If you basically round off, the math tells you that a beat of that size should equal about an extra billion dollars in revenue. Going into the report, the street was exactly at $13 billion for its Q3 average, but take a look at where we are now.\nSource: Seeking Alpha analyst estimates page\nDespite the large deliveries beat, the street average hasn't even risen by $650 million, so the consensus seems to be a bit low right now. Additionally, the \"low\" estimate seems completely off base, as that would represent a decline over Q2's top line figure despite an extra roughly 40,000 deliveries. Don't forget, the sequential jump in Model S cash deliveries was around 6,000 units, which at an average selling price of $100,000 is an additional $600 million in revenue alone. Taking the low estimate out would increase the street average by $100 million. Unless there was some massive discounting going on or some prior period adjustment, any revenue estimates around or below $13 billion just don't seem logical.\nModel Y sales to Europe, more Model S sales (including the expensive Plaid), and a full quarter of price raises in the US should all be tailwinds. The standard range Y in China will provide somewhat of a headwind, along with a slightly stronger dollar in the quarter. However, Tesla may be able to potentially recognize hundreds of millions of dollars in deferred revenue related to its full self-driving feature as that program expanded a bit during the quarter. I also am projecting a $100 million sequential decline in credit sales.\nPerhaps the biggest question in the quarter will be margins. All of those price hikes, the mix of more Model Y and new Model S, and the ramp of production in China should be positives, potentially offsetting some or all supply chain or chip shortage inflation. In my base case, I'm assuming that total automotive gross margins increase by one percentage point, or a little more than half of the 190 basis points they jumped from Q1 to Q2. As I usually do, the table below shows a bear, base, and bull case, with dollar values in millions except per share amounts.\nI'm sure there will be critics who think I'm just trying to set a high bar so that Tesla cannot beat my base case. That is not true here, as on the revenue side I'm not even halfway between the street average and the high estimate on the street. On the bottom line, I'm not even calling for Tesla to beat by as much as it did in Q2 (47 cents). Also, using the average jump from Q2 to Q3 non-GAAP earnings per share over the past three years would put us a bit above $2 per share, and I'm still calling for a one handle there. For Tesla to miss estimates on the bottom line, gross margins would have to drop by about a percentage point sequentially. Even then, a little revenue upside or savings on the operating expense lines could still fuel a bottom line beat.\nThe other major item investors will be watching for is an update on Tesla's production facilities. It appears that Shanghai 3/Y production is now greater than Fremont's, and the Berlin and Texas factories are still on track to open this year. The company needs these facilities to come online in the next few months if it wants to hit a 50% yearly growth rate for 2022, likely meaning over 1.3 million deliveries. Any Tesla-specific delays that linger meaningfully into the new year may also impact other new products (Semi, Cybertruck, new Roadster) that have already been delayed a bit, as well as allowing the competition to potentially steal some market share. In the past few days, Tesla removed the Cybertruck's specifications and prices from its website. This may have to do with surging commodity costs since that product was unveiled, and it likely means Tesla will raise prices when production finally starts.\nAs for Tesla shares, they are currently in a very nice uptrend and have broken solidly above $800 after the Q3 delivery report. As the chart below shows, the 50-day moving average (pink line) has crossed back above its longer term counterpart (200-day in purple). The stock closed Friday less than $60 from its all-time high, so the only concern here might be that the earnings report could be the old \"buy the rumor, sell the news\" type of event.\nSource: Yahoo! Finance\nTesla is set to report Q3 earnings this week, and it would not surprise me if we see the company beat again. Given the sharp sequential rise in deliveries, the street seems a bit low with some of its estimates, and any margin increases would likely mean a significant bottom line beat. Investors will be looking for updates on production capacities, not only to see if Berlin and Texas are close to being ready, but to start thinking about how far over one million deliveries Tesla could get next year. It certainly will be interesting to see the stock's reaction afterwards, as the recent rally may mean investors are pricing in another big beat.","news_type":1},"isVote":1,"tweetType":1,"viewCount":491,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821147450,"gmtCreate":1633710001100,"gmtModify":1633710157295,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Loke","listText":"Loke","text":"Loke","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821147450","repostId":"2173925535","repostType":4,"repost":{"id":"2173925535","pubTimestamp":1633701180,"share":"https://www.laohu8.com/m/news/2173925535?lang=&edition=full","pubTime":"2021-10-08 21:53","market":"us","language":"en","title":"5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2173925535","media":"Motley Fool","summary":"Riding the Oracle of Omaha's coattails has long been a moneymaking strategy.","content":"<blockquote>\n <b>Riding the <a href=\"https://laohu8.com/S/ORCL\">Oracle</a> of Omaha's coattails has long been a moneymaking strategy.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>Buffett has delivered an average annual return of 20% for his company's shareholders, dating back to 1965.</li>\n <li><a href=\"https://laohu8.com/S/BRK.A\">Berkshire Hathaway</a>'s investment portfolio is packed with growth and value stocks that are ripe for the picking.</li>\n</ul>\n<p>If you've ever wondered why Wall Street and retail investors pay such close attention to billionaire Warren Buffett, it's because he has an impeccable moneymaking track record.</p>\n<p>Since taking over as CEO of <b><a href=\"https://laohu8.com/S/BRK.B\">Berkshire Hathaway</a></b> (NYSE:BRK.A)(NYSE:BRK.B) in 1965, the Oracle of Omaha has overseen the creation of nearly $600 billion in market value for shareholders, and delivered an average annual return of 20% for the company's Class A shares. Including year-to-date gains, we're talking about an increase of approximately 3,300,000%! Riding Buffett's coattails has long been a profitable venture.</p>\n<p>As we push into the fourth quarter, five Warren Buffett stocks look particularly attractive and can confidently be bought hand over fist by investors.</p>\n<p><img src=\"https://static.tigerbbs.com/1077c8372814d2b8150e933b4c608005\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.</p>\n<h3><a href=\"https://laohu8.com/S/GM\">General Motors</a></h3>\n<p>One of the best deals long-term investors are going to find in Berkshire Hathaway's portfolio at the moment is auto stock <b><a href=\"https://laohu8.com/S/BGC\">General</a> Motors</b> (NYSE:GM).</p>\n<p>Like most automakers, GM has had to contend with two big hurdles over the past 18 months. <a href=\"https://laohu8.com/S/FBNC\">First</a>, the pandemic caused consumers to scale back on major purchases, which reduced short-term auto sales at the dealership level. And second, supply chain issues in the wake of the pandemic have caused GM and other automakers to lower or halt production on certain models. While these concerns are tangible, they're not a long-term worry. This means whatever short-term pain General Motors is experiencing is an opportunity for patient investors to pounce.</p>\n<p>The real excitement for GM has to do with the electrification of consumer and enterprise auto fleets. In an effort to combat climate change, we're liable to see a multi-decade vehicle replacement cycle that almost exclusively emphasizes electric-powered vehicles. For its part, General Motors is investing $35 billion in electric vehicle (EVs), autonomous vehicle, and battery research through 2025. By mid-decade, the company expects to have launched 30 new EVs globally.</p>\n<p>While General Motors has long been a key player in its home market, the U.S., it's no slouch in the world's biggest auto market, either. GM is on pace to sell about 3 million vehicles in <a href=\"https://laohu8.com/S/CAAS\">China</a> this year (based on sales through the first six months), and has the deep pockets and infrastructure capable of gobbling up EV market share in the world's second-largest economy by gross domestic product.</p>\n<p>Long story short, a forward price-to-earnings (P/E) ratio of 8 no longer makes sense for a company whose growth rate could sustainably pick up for decades.</p>\n<p><img src=\"https://static.tigerbbs.com/cf0f5b723e57653031556b63cd5a86db\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>Bristol <a href=\"https://laohu8.com/S/MYE\">Myers</a> Squibb</h3>\n<p>Value stocks have always been a big theme for Warren Buffett, and that's exactly what investors are going to get with pharmaceutical stock <b>Bristol Myers Squibb</b> (NYSE:BMY).</p>\n<p>Like most healthcare stocks, Bristol Myers' products are highly defensive. This is to say that a stock market decline or even an economic contraction won't adversely affect demand for its pharmaceuticals. Since we don't get to choose when we get sick or what ailment(s) we develop, drugmakers like Bristol Myers usually offer highly predictable cash flow.</p>\n<p>One company-specific reason investors can buy this Warren Buffett stock hand over fist for the fourth quarter is its organic growth opportunity. Eliquis, which was developed with <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>, has become the most-popular oral anticoagulant in the world and should bring in more than $10 billion in sales for Bristol Myers Squibb this year. There's also cancer immunotherapy Opdivo, which I believe offers even more long-term opportunity. Although Opdivo flamed out in advanced lung cancer trials a few years back, it's being examined in dozens of clinical trials and has a very good chance to generate billions in added annual revenue via label expansion opportunities.</p>\n<p>Bristol Myers' acquisition of cancer and immunology drugmaker <a href=\"https://laohu8.com/S/CELG\">Celgene</a> in late 2019 gets high marks, too. Buying Celgene brought multiple myeloma drug Revlimid into Bristol's portfolio. Revlimid brought in over $12 billion in sales last year, and has a track record of maintaining double-digit annual sales growth. This key therapy is protected from an onslaught of generic competition until the end of January 2026.</p>\n<p>There aren't many better values right now than Bristol Myers Squibb at less than 8 times Wall Street's forward-year earnings forecast.</p>\n<p><img src=\"https://static.tigerbbs.com/d80a8204e79140f358607acd8fb20af9\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3><a href=\"https://laohu8.com/S/TEVA\">Teva Pharmaceutical</a> Industries</h3>\n<p>In terms of valuation, no Warren Buffett stock is cheaper than brand-name and generic-drug company <b>Teva Pharmaceutical Industries</b> (NYSE:TEVA). Shares of the company can be scooped up by investors right now for under 4 times forecasted earnings per share in 2021.</p>\n<p>How does a profitable company in a defensive sector get pushed to such a low multiple? The truth is Teva has had a lot of things go wrong over the past five years. It overpaid for generic-drug company Actavis, which ballooned its debt, and it's found itself in the crosshairs of litigation on more than <a href=\"https://laohu8.com/S/AONE.U\">one</a> occasion. In fact, most U.S. states are litigating against Teva regarding its role in opioid crisis. The uncertainty surrounding these cases is primarily responsible for keeping Teva's valuation in check.</p>\n<p>Thankfully, Teva has a secret weapon: CEO Kare Schultz. Schultz was hired in late 2017 as a turnaround specialist, and through nearly four years with the company he's worked wonders. Billions in annual operating expenses have been shed, and the company's net debt has shrunk from more than $34 billion when he took over to less than $24 billion. At the current trajectory, Teva could have around $15 billion in net debt by the end of 2023.</p>\n<p>What's more, Schultz has the acumen to work out settlements for Teva's remaining legal issues. Considering Teva's debt position, Schultz is angling to offer free or discounted products, rather than pay cash. With most other drugmakers settling their opioid lawsuits, it seems to be just a matter of time before this gray cloud clears up and Teva returns to a fair valuation multiple.</p>\n<p><img src=\"https://static.tigerbbs.com/fc80e4dea1a6f3868ca4f03e6ea300ae\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3><a href=\"https://laohu8.com/S/V\">Visa</a> and Mastercard</h3>\n<p>The final two Warren Buffett stocks to buy hand over fist for the fourth quarter are being lumped together for good reason: They're chief competitors and two of the most dominant companies in the payment-processing landscape, <b><a href=\"https://laohu8.com/S/V\">Visa</a></b> (NYSE:V) and <b>Mastercard</b> (NYSE:MA).</p>\n<p>The reason Visa and Mastercard have performed so well for so long is because they're cyclically tied companies. Although economic contractions and recessions are inevitable, they usually only last for a few months to a couple of quarters. Comparatively, periods of economic expansion last years. Payment processors Visa and Mastercard are simply benefiting from these disproportionately longer periods of expansion.</p>\n<p>This dynamic duo also outperforms because they strictly stick to payment processing and aren't direct lenders. While it could be argued that they're giving up the opportunity to generate interest income and fees during these long-winded expansions, they're also shielded from a rise in credit delinquencies during economic contractions and recessions. Not having to set aside capital to cover credit delinquencies is a big reason why their profit margins remain so consistently high.</p>\n<p>There's also a long runway for organic expansion with both companies. Most global transactions are still be conducted in cash, and a number of regions are remain underbanked (e.g., Southeastern Asia, the Middle East, and Africa). Pushing their payment infrastructure into these regions should allow Visa and Mastercard to sustain high single-digit sales growth for a long time to come.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-08 21:53 GMT+8 <a href=https://www.fool.com/investing/2021/10/08/5-warren-buffett-stocks-to-buy-for-fourth-quarter/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Riding the Oracle of Omaha's coattails has long been a moneymaking strategy.\n\nKey Points\n\nBuffett has delivered an average annual return of 20% for his company's shareholders, dating back to 1965.\n...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/08/5-warren-buffett-stocks-to-buy-for-fourth-quarter/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","BRK.A":"伯克希尔","BMY":"施贵宝","BRK.B":"伯克希尔B","TEVA":"梯瓦制药","V":"Visa","MA":"万事达"},"source_url":"https://www.fool.com/investing/2021/10/08/5-warren-buffett-stocks-to-buy-for-fourth-quarter/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173925535","content_text":"Riding the Oracle of Omaha's coattails has long been a moneymaking strategy.\n\nKey Points\n\nBuffett has delivered an average annual return of 20% for his company's shareholders, dating back to 1965.\nBerkshire Hathaway's investment portfolio is packed with growth and value stocks that are ripe for the picking.\n\nIf you've ever wondered why Wall Street and retail investors pay such close attention to billionaire Warren Buffett, it's because he has an impeccable moneymaking track record.\nSince taking over as CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) in 1965, the Oracle of Omaha has overseen the creation of nearly $600 billion in market value for shareholders, and delivered an average annual return of 20% for the company's Class A shares. Including year-to-date gains, we're talking about an increase of approximately 3,300,000%! Riding Buffett's coattails has long been a profitable venture.\nAs we push into the fourth quarter, five Warren Buffett stocks look particularly attractive and can confidently be bought hand over fist by investors.\n\nBerkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.\nGeneral Motors\nOne of the best deals long-term investors are going to find in Berkshire Hathaway's portfolio at the moment is auto stock General Motors (NYSE:GM).\nLike most automakers, GM has had to contend with two big hurdles over the past 18 months. First, the pandemic caused consumers to scale back on major purchases, which reduced short-term auto sales at the dealership level. And second, supply chain issues in the wake of the pandemic have caused GM and other automakers to lower or halt production on certain models. While these concerns are tangible, they're not a long-term worry. This means whatever short-term pain General Motors is experiencing is an opportunity for patient investors to pounce.\nThe real excitement for GM has to do with the electrification of consumer and enterprise auto fleets. In an effort to combat climate change, we're liable to see a multi-decade vehicle replacement cycle that almost exclusively emphasizes electric-powered vehicles. For its part, General Motors is investing $35 billion in electric vehicle (EVs), autonomous vehicle, and battery research through 2025. By mid-decade, the company expects to have launched 30 new EVs globally.\nWhile General Motors has long been a key player in its home market, the U.S., it's no slouch in the world's biggest auto market, either. GM is on pace to sell about 3 million vehicles in China this year (based on sales through the first six months), and has the deep pockets and infrastructure capable of gobbling up EV market share in the world's second-largest economy by gross domestic product.\nLong story short, a forward price-to-earnings (P/E) ratio of 8 no longer makes sense for a company whose growth rate could sustainably pick up for decades.\n\nImage source: Getty Images.\nBristol Myers Squibb\nValue stocks have always been a big theme for Warren Buffett, and that's exactly what investors are going to get with pharmaceutical stock Bristol Myers Squibb (NYSE:BMY).\nLike most healthcare stocks, Bristol Myers' products are highly defensive. This is to say that a stock market decline or even an economic contraction won't adversely affect demand for its pharmaceuticals. Since we don't get to choose when we get sick or what ailment(s) we develop, drugmakers like Bristol Myers usually offer highly predictable cash flow.\nOne company-specific reason investors can buy this Warren Buffett stock hand over fist for the fourth quarter is its organic growth opportunity. Eliquis, which was developed with Pfizer, has become the most-popular oral anticoagulant in the world and should bring in more than $10 billion in sales for Bristol Myers Squibb this year. There's also cancer immunotherapy Opdivo, which I believe offers even more long-term opportunity. Although Opdivo flamed out in advanced lung cancer trials a few years back, it's being examined in dozens of clinical trials and has a very good chance to generate billions in added annual revenue via label expansion opportunities.\nBristol Myers' acquisition of cancer and immunology drugmaker Celgene in late 2019 gets high marks, too. Buying Celgene brought multiple myeloma drug Revlimid into Bristol's portfolio. Revlimid brought in over $12 billion in sales last year, and has a track record of maintaining double-digit annual sales growth. This key therapy is protected from an onslaught of generic competition until the end of January 2026.\nThere aren't many better values right now than Bristol Myers Squibb at less than 8 times Wall Street's forward-year earnings forecast.\n\nImage source: Getty Images.\nTeva Pharmaceutical Industries\nIn terms of valuation, no Warren Buffett stock is cheaper than brand-name and generic-drug company Teva Pharmaceutical Industries (NYSE:TEVA). Shares of the company can be scooped up by investors right now for under 4 times forecasted earnings per share in 2021.\nHow does a profitable company in a defensive sector get pushed to such a low multiple? The truth is Teva has had a lot of things go wrong over the past five years. It overpaid for generic-drug company Actavis, which ballooned its debt, and it's found itself in the crosshairs of litigation on more than one occasion. In fact, most U.S. states are litigating against Teva regarding its role in opioid crisis. The uncertainty surrounding these cases is primarily responsible for keeping Teva's valuation in check.\nThankfully, Teva has a secret weapon: CEO Kare Schultz. Schultz was hired in late 2017 as a turnaround specialist, and through nearly four years with the company he's worked wonders. Billions in annual operating expenses have been shed, and the company's net debt has shrunk from more than $34 billion when he took over to less than $24 billion. At the current trajectory, Teva could have around $15 billion in net debt by the end of 2023.\nWhat's more, Schultz has the acumen to work out settlements for Teva's remaining legal issues. Considering Teva's debt position, Schultz is angling to offer free or discounted products, rather than pay cash. With most other drugmakers settling their opioid lawsuits, it seems to be just a matter of time before this gray cloud clears up and Teva returns to a fair valuation multiple.\n\nImage source: Getty Images.\nVisa and Mastercard\nThe final two Warren Buffett stocks to buy hand over fist for the fourth quarter are being lumped together for good reason: They're chief competitors and two of the most dominant companies in the payment-processing landscape, Visa (NYSE:V) and Mastercard (NYSE:MA).\nThe reason Visa and Mastercard have performed so well for so long is because they're cyclically tied companies. Although economic contractions and recessions are inevitable, they usually only last for a few months to a couple of quarters. Comparatively, periods of economic expansion last years. Payment processors Visa and Mastercard are simply benefiting from these disproportionately longer periods of expansion.\nThis dynamic duo also outperforms because they strictly stick to payment processing and aren't direct lenders. While it could be argued that they're giving up the opportunity to generate interest income and fees during these long-winded expansions, they're also shielded from a rise in credit delinquencies during economic contractions and recessions. Not having to set aside capital to cover credit delinquencies is a big reason why their profit margins remain so consistently high.\nThere's also a long runway for organic expansion with both companies. Most global transactions are still be conducted in cash, and a number of regions are remain underbanked (e.g., Southeastern Asia, the Middle East, and Africa). Pushing their payment infrastructure into these regions should allow Visa and Mastercard to sustain high single-digit sales growth for a long time to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":430,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865108666,"gmtCreate":1632959230203,"gmtModify":1632959230459,"author":{"id":"3575517733011286","authorId":"3575517733011286","name":"UpUpUpUpUp","avatar":"https://static.tigerbbs.com/f92e5e26e6e720eda3643248da3c21eb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865108666","repostId":"2171115602","repostType":4,"repost":{"id":"2171115602","pubTimestamp":1632935460,"share":"https://www.laohu8.com/m/news/2171115602?lang=&edition=full","pubTime":"2021-09-30 01:11","market":"us","language":"en","title":"Eyewear maker Warby Parker spikes 34% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2171115602","media":"MarketWatch","summary":"Eyewear maker Warby Parker spikes 34% on its first day of trading.\n\nNYSE assigns reference price of ","content":"<p>Eyewear maker Warby Parker spikes 34% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/f145f99950734ec9b0e3b675836a53fb\" tg-width=\"1836\" tg-height=\"901\" referrerpolicy=\"no-referrer\"></p>\n<p>NYSE assigns reference price of $40, trading to begin Wednesday</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5917e3b384716a3bbcfdd5860b35711f\" tg-width=\"700\" tg-height=\"628\" referrerpolicy=\"no-referrer\"><span>Warby Parker is focused on both business and giving back, the prospectus says.</span></p>\n<p><a href=\"https://laohu8.com/S/WRBY\">Warby Parker Inc.</a>, the company known for its affordable eyeglasses sold online, through its app and in stores, is begining trading Wednesday in a direct listing.</p>\n<p>On Tuesday, the New York Stock Exchange assigned a $40 reference price to the New York City-based company's listing, which is expected to begin trading Wednesday under the ticker symbol \"WRBY\" . The company has about 111.5 million shares outstanding, giving it a valuation around $4.6 billion at that reference price.</p>\n<p>Reference prices for direct listings are based on trading prices in private markets ahead of companies filing with the Securities and Exchange Commission for a public listing. Direct listings differ from IPOs because there is no capital raised, which is what places a dollar figure on shares in an IPO. Direct listings are largely expected to trade higher than the reference price.</p>\n<p>Warby Parker will offer class A stock, eligible for one vote per share; class B stock, which entitles shareholders to 10 votes per share and can be converted to class A shares; and class C shares, which carry no voting rights.</p>\n<p>Warby Parker will be an emerging growth company, which means it does not have to make the same disclosures required of bigger public companies. A business remains an emerging growth company until it reaches a number of milestones, including annual revenue of more than $1.07 billion.</p>\n<p>Neil Blumenthal and Dave Gilboa, ages 41 and 40 respectively, are co-founders, co-chairs and co-chief executives of the company.</p>\n<p>Prior to Warby Parker, Blumenthal was a director at VisionSpring, a nonprofit that trains men and women in developing countries to sell affordable eyewear. Blumenthal is also a director at Allbirds, which filed to go public this week, at salad chain Sweetgreen and a number of nonprofit organizations including Warby Parker Impact Foundation and RxArt.</p>\n<p>Gilboa worked at consulting firm Bain & Company and merchant bank Allen & Co. prior to Warby Parker. He also serves on the board of the Warby Parker Impact Foundation.</p>\n<p>Andrew Hunt and Jeffrey Raider, both age 40, are the other two co-founders of Warby Parker and both serve as directors. Also on the board is Ronald Williams, age 71, and former CEO of Aetna from 2006 to 2010.</p>\n<p>Warby Parker was founded in 2010 and inspired by the founders' concerns that glasses were expensive and the process of buying them inconvenient.</p>\n<p>In its prospectus, Warby Parker says it is driven to do good and make customers happy. In addition to making glasses more affordable, Warby Parker has distributed more than 8 million pairs of glasses through the Buy a Pair, Give a Pair program. The company is also carbon neutral, which it has achieved through purchasing offsets.</p>\n<p>\"[This motivation] pushes us to defy convention -- and, at times, to forego short-term profits -- but we believe delivering remarkable customer experiences and making a positive impact on all stakeholders will lead to continued long-term sustainable growth and profitability,\" says a letter from the co-CEOs included in the prospectus.</p>\n<p>A pair of Warby Parker spectacles starts at a price of $95 including prescription lenses, and can be purchased digitally, using a free home try-on system or virtual trial system, as well as at145 Warby Parker shops. The company keeps prices low by selling direct-to-consumer and bypassing middlemen.</p>\n<p>The company had a net loss of $55.9 million in 2020, after breakeven in 2019 and a loss of $22.9 million in 2018. It chalked up $393.7 million of revenue in 2020, up from $370.5 million in 2019.</p>\n<p>Some 95% of net revenue in 2020 came from the sale of glasses, 2% of revenue was generated by the sale of contact lenses, 1% by eye exams and 2% by eyewear accessories. The company is expecting to expand its customer base for eye exams.</p>\n<p>For the six months ending June 30, 2021, net losses were $7.3 million and revenue totaled $270.5 million. The company has more than two million active customers and nearly 3,000 workers.</p>\n<p><img src=\"https://static.tigerbbs.com/3510dd6c717e636f33784d4f89bd9ce3\" tg-width=\"506\" tg-height=\"706\" referrerpolicy=\"no-referrer\"></p>\n<p>About 76% of Americans were using some kind of vision correction in 2020, according to data provided by the prospectus. The number of Americans ages 65 and over will more than double over the next 40 years and at least 84% of people in this older age group wear corrective lenses. Increasing use of screens like mobile devices and computers has contributed to the need for vision correction. Glasses are replaced every two-to-two-and-a-half years.</p>\n<p>Warby Parker says that between 2015 and 2019, it had a 50% sales retention rate within two years of the first purchase among customers it acquired. The retention rate was nearly 100% after four years during that same period.</p>\n<p>The vision care industry is expected to grow at a 9.2% compound annual growth rate (CAGR) between 2020 and 2025, according to Statista data provided in the prospectus.</p>\n<p>Here are five other things to know about Warby Parker before it goes public:</p>\n<p><b>Most decision-making power will be in the hands of Warby Parker's co-founders and co-CEOs</b></p>\n<p>The company's stock structure post-IPO will give the company's founders and top executives considerable control that could last until Oct. 1, 2031.</p>\n<p>\"Because of the ten-to-one voting ratio between our class B and class A common stock, our co-founders and co-CEOs collectively could continue to control a significant percentage of the combined voting power of our common stock and therefore would be able to control all matters submitted to our stockholders for approval until the date of automatic conversion, when all shares outstanding of Class B common stock will convert automatically into shares of Class A common stock,\" the prospectus says.</p>\n<p>That means other shareholders will have little say in the running of the company and will not influence such decisions as the election of directors, amendments of organizational documents, and any merger, consolidation, or sale of some or all of its assets.</p>\n<p>As a loss-making company, it will not pay a dividend for the foreseeable future.</p>\n<p><b>Warby Parker does most things in-house -- and that could limit its ability to grow</b></p>\n<p>Warby Parker says its business model, which has it do most things in-house, could cause problems.</p>\n<p>\"[T]he vertically integrated nature of our business, where we design all of our own glasses in our New York headquarters, contract manufacture all of our glass frames, fulfill the glasses we sell at our own optical and fulfillment laboratories as well as at third-party contract laboratories, sell our products exclusively through our own retail stores, e-commerce site and mobile application, and service our products, exposes us to risk and disruption at many points that are critical to successfully operating our business, and may make it more difficult for us to scale our business,\" the prospectus says.</p>\n<p><b>Supply chain troubles outside of those caused by COVID-19 could arise</b></p>\n<p>Supply chain problems have plagued companies across the consumer space this year. But the company warns that its operations are vulnerable to other challenges as well.</p>\n<p>Warby Parker gets more than half of the cellulose acetate used in its frames from a single supplier. Other components are sourced from the U.S., China, Italy, Vietnam, and Japan. The company also uses third-party contractors on certain items, but doesn't have long-term contracts with these suppliers.</p>\n<p>\"We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or modify components used in our products,\" the prospectus says.</p>\n<p>\"We may in the future experience component shortages, and the predictability of the availability of these components may be limited, which may be heightened in light of the ongoing COVID-19 pandemic.\"</p>\n<p><b>Warby Parker says customers are slow to adopt e-commerce for eyeglasses</b></p>\n<p>Warby Parker offers online shopping for eyeglasses, one of the most significant ways the company differentiates itself from a crowded competitive field. But the company says many customers are more comfortable shopping for eyeglasses in person.</p>\n<p>\"Improving upon the consumer in-store experience through an online platform is difficult due to broad consumer demands on selection, quality, convenience, and affordability,\" the prospectus says.</p>\n<p>When the company first started, less than 2.5% of glasses were purchased online. Even now, the company says it has \"historically generated a significant portion of our revenue from our retail stores, and our growth strategy will depend, in large part, on acquiring customers through the growth of our retail store base and expansion of our existing retail store operations.\"</p>\n<p><b>Warby Parker's business is actually seasonal</b></p>\n<p>Customers eager to use health benefits before the end of a calendar year tend to boost demand in December.</p>\n<p>\"Consistent with our policy to recognize revenue upon order delivery, any orders placed at the end of December are recognized as revenue upon delivery which may occur in the following year,\" Warby Parker said.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eyewear maker Warby Parker spikes 34% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEyewear maker Warby Parker spikes 34% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 01:11 GMT+8 <a href=https://www.marketwatch.com/story/warby-parker-ipo-5-things-to-know-about-the-affordable-eyeglass-maker-before-its-direct-listing-11630520146?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Eyewear maker Warby Parker spikes 34% on its first day of trading.\n\nNYSE assigns reference price of $40, trading to begin Wednesday\nWarby Parker is focused on both business and giving back, the ...</p>\n\n<a href=\"https://www.marketwatch.com/story/warby-parker-ipo-5-things-to-know-about-the-affordable-eyeglass-maker-before-its-direct-listing-11630520146?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/warby-parker-ipo-5-things-to-know-about-the-affordable-eyeglass-maker-before-its-direct-listing-11630520146?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171115602","content_text":"Eyewear maker Warby Parker spikes 34% on its first day of trading.\n\nNYSE assigns reference price of $40, trading to begin Wednesday\nWarby Parker is focused on both business and giving back, the prospectus says.\nWarby Parker Inc., the company known for its affordable eyeglasses sold online, through its app and in stores, is begining trading Wednesday in a direct listing.\nOn Tuesday, the New York Stock Exchange assigned a $40 reference price to the New York City-based company's listing, which is expected to begin trading Wednesday under the ticker symbol \"WRBY\" . The company has about 111.5 million shares outstanding, giving it a valuation around $4.6 billion at that reference price.\nReference prices for direct listings are based on trading prices in private markets ahead of companies filing with the Securities and Exchange Commission for a public listing. Direct listings differ from IPOs because there is no capital raised, which is what places a dollar figure on shares in an IPO. Direct listings are largely expected to trade higher than the reference price.\nWarby Parker will offer class A stock, eligible for one vote per share; class B stock, which entitles shareholders to 10 votes per share and can be converted to class A shares; and class C shares, which carry no voting rights.\nWarby Parker will be an emerging growth company, which means it does not have to make the same disclosures required of bigger public companies. A business remains an emerging growth company until it reaches a number of milestones, including annual revenue of more than $1.07 billion.\nNeil Blumenthal and Dave Gilboa, ages 41 and 40 respectively, are co-founders, co-chairs and co-chief executives of the company.\nPrior to Warby Parker, Blumenthal was a director at VisionSpring, a nonprofit that trains men and women in developing countries to sell affordable eyewear. Blumenthal is also a director at Allbirds, which filed to go public this week, at salad chain Sweetgreen and a number of nonprofit organizations including Warby Parker Impact Foundation and RxArt.\nGilboa worked at consulting firm Bain & Company and merchant bank Allen & Co. prior to Warby Parker. He also serves on the board of the Warby Parker Impact Foundation.\nAndrew Hunt and Jeffrey Raider, both age 40, are the other two co-founders of Warby Parker and both serve as directors. Also on the board is Ronald Williams, age 71, and former CEO of Aetna from 2006 to 2010.\nWarby Parker was founded in 2010 and inspired by the founders' concerns that glasses were expensive and the process of buying them inconvenient.\nIn its prospectus, Warby Parker says it is driven to do good and make customers happy. In addition to making glasses more affordable, Warby Parker has distributed more than 8 million pairs of glasses through the Buy a Pair, Give a Pair program. The company is also carbon neutral, which it has achieved through purchasing offsets.\n\"[This motivation] pushes us to defy convention -- and, at times, to forego short-term profits -- but we believe delivering remarkable customer experiences and making a positive impact on all stakeholders will lead to continued long-term sustainable growth and profitability,\" says a letter from the co-CEOs included in the prospectus.\nA pair of Warby Parker spectacles starts at a price of $95 including prescription lenses, and can be purchased digitally, using a free home try-on system or virtual trial system, as well as at145 Warby Parker shops. The company keeps prices low by selling direct-to-consumer and bypassing middlemen.\nThe company had a net loss of $55.9 million in 2020, after breakeven in 2019 and a loss of $22.9 million in 2018. It chalked up $393.7 million of revenue in 2020, up from $370.5 million in 2019.\nSome 95% of net revenue in 2020 came from the sale of glasses, 2% of revenue was generated by the sale of contact lenses, 1% by eye exams and 2% by eyewear accessories. The company is expecting to expand its customer base for eye exams.\nFor the six months ending June 30, 2021, net losses were $7.3 million and revenue totaled $270.5 million. The company has more than two million active customers and nearly 3,000 workers.\n\nAbout 76% of Americans were using some kind of vision correction in 2020, according to data provided by the prospectus. The number of Americans ages 65 and over will more than double over the next 40 years and at least 84% of people in this older age group wear corrective lenses. Increasing use of screens like mobile devices and computers has contributed to the need for vision correction. Glasses are replaced every two-to-two-and-a-half years.\nWarby Parker says that between 2015 and 2019, it had a 50% sales retention rate within two years of the first purchase among customers it acquired. The retention rate was nearly 100% after four years during that same period.\nThe vision care industry is expected to grow at a 9.2% compound annual growth rate (CAGR) between 2020 and 2025, according to Statista data provided in the prospectus.\nHere are five other things to know about Warby Parker before it goes public:\nMost decision-making power will be in the hands of Warby Parker's co-founders and co-CEOs\nThe company's stock structure post-IPO will give the company's founders and top executives considerable control that could last until Oct. 1, 2031.\n\"Because of the ten-to-one voting ratio between our class B and class A common stock, our co-founders and co-CEOs collectively could continue to control a significant percentage of the combined voting power of our common stock and therefore would be able to control all matters submitted to our stockholders for approval until the date of automatic conversion, when all shares outstanding of Class B common stock will convert automatically into shares of Class A common stock,\" the prospectus says.\nThat means other shareholders will have little say in the running of the company and will not influence such decisions as the election of directors, amendments of organizational documents, and any merger, consolidation, or sale of some or all of its assets.\nAs a loss-making company, it will not pay a dividend for the foreseeable future.\nWarby Parker does most things in-house -- and that could limit its ability to grow\nWarby Parker says its business model, which has it do most things in-house, could cause problems.\n\"[T]he vertically integrated nature of our business, where we design all of our own glasses in our New York headquarters, contract manufacture all of our glass frames, fulfill the glasses we sell at our own optical and fulfillment laboratories as well as at third-party contract laboratories, sell our products exclusively through our own retail stores, e-commerce site and mobile application, and service our products, exposes us to risk and disruption at many points that are critical to successfully operating our business, and may make it more difficult for us to scale our business,\" the prospectus says.\nSupply chain troubles outside of those caused by COVID-19 could arise\nSupply chain problems have plagued companies across the consumer space this year. But the company warns that its operations are vulnerable to other challenges as well.\nWarby Parker gets more than half of the cellulose acetate used in its frames from a single supplier. Other components are sourced from the U.S., China, Italy, Vietnam, and Japan. The company also uses third-party contractors on certain items, but doesn't have long-term contracts with these suppliers.\n\"We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or modify components used in our products,\" the prospectus says.\n\"We may in the future experience component shortages, and the predictability of the availability of these components may be limited, which may be heightened in light of the ongoing COVID-19 pandemic.\"\nWarby Parker says customers are slow to adopt e-commerce for eyeglasses\nWarby Parker offers online shopping for eyeglasses, one of the most significant ways the company differentiates itself from a crowded competitive field. But the company says many customers are more comfortable shopping for eyeglasses in person.\n\"Improving upon the consumer in-store experience through an online platform is difficult due to broad consumer demands on selection, quality, convenience, and affordability,\" the prospectus says.\nWhen the company first started, less than 2.5% of glasses were purchased online. Even now, the company says it has \"historically generated a significant portion of our revenue from our retail stores, and our growth strategy will depend, in large part, on acquiring customers through the growth of our retail store base and expansion of our existing retail store operations.\"\nWarby Parker's business is actually seasonal\nCustomers eager to use health benefits before the end of a calendar year tend to boost demand in December.\n\"Consistent with our policy to recognize revenue upon order delivery, any orders placed at the end of December are recognized as revenue upon delivery which may occur in the following year,\" Warby Parker said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}